Nothing Special   »   [go: up one dir, main page]

US20080065139A1 - Expandable preformed structures for deployment in interior body regions - Google Patents

Expandable preformed structures for deployment in interior body regions Download PDF

Info

Publication number
US20080065139A1
US20080065139A1 US11/978,412 US97841207A US2008065139A1 US 20080065139 A1 US20080065139 A1 US 20080065139A1 US 97841207 A US97841207 A US 97841207A US 2008065139 A1 US2008065139 A1 US 2008065139A1
Authority
US
United States
Prior art keywords
bone
expandable
expanded
volume
cancellous bone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/978,412
Inventor
Robert Scribner
Karen Talmadge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orthophoenix LLC
Original Assignee
Kyphon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22211509&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20080065139(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kyphon Inc filed Critical Kyphon Inc
Priority to US11/978,412 priority Critical patent/US20080065139A1/en
Publication of US20080065139A1 publication Critical patent/US20080065139A1/en
Assigned to MEDTRONIC SPINE LLC reassignment MEDTRONIC SPINE LLC CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: KYPHON INC
Assigned to KYPHON SARL reassignment KYPHON SARL ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MEDTRONIC SPINE LLC
Assigned to ORTHOPHOENIX, LLC reassignment ORTHOPHOENIX, LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: KYPHON SARL
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/56Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
    • A61B17/58Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws, setting implements or the like
    • A61B17/68Internal fixation devices, including fasteners and spinal fixators, even if a part thereof projects from the skin
    • A61B17/70Spinal positioners or stabilisers ; Bone stabilisers comprising fluid filler in an implant
    • A61B17/7097Stabilisers comprising fluid filler in an implant, e.g. balloon; devices for inserting or filling such implants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/56Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
    • A61B17/58Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws, setting implements or the like
    • A61B17/88Osteosynthesis instruments; Methods or means for implanting or extracting internal or external fixation devices
    • A61B17/885Tools for expanding or compacting bones or discs or cavities therein
    • A61B17/8852Tools for expanding or compacting bones or discs or cavities therein capable of being assembled or enlarged, or changing shape, inside the bone or disc
    • A61B17/8855Tools for expanding or compacting bones or discs or cavities therein capable of being assembled or enlarged, or changing shape, inside the bone or disc inflatable, e.g. kyphoplasty balloons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/002Packages specially adapted therefor ; catheter kit packages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M29/00Dilators with or without means for introducing media, e.g. remedies
    • A61M29/02Dilators made of swellable material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/34Trocars; Puncturing needles
    • A61B17/3472Trocars; Puncturing needles for bones, e.g. intraosseus injections
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00526Methods of manufacturing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00535Surgical instruments, devices or methods, e.g. tourniquets pneumatically or hydraulically operated
    • A61B2017/00539Surgical instruments, devices or methods, e.g. tourniquets pneumatically or hydraulically operated hydraulically
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00535Surgical instruments, devices or methods, e.g. tourniquets pneumatically or hydraulically operated
    • A61B2017/00544Surgical instruments, devices or methods, e.g. tourniquets pneumatically or hydraulically operated pneumatically
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00535Surgical instruments, devices or methods, e.g. tourniquets pneumatically or hydraulically operated
    • A61B2017/00557Surgical instruments, devices or methods, e.g. tourniquets pneumatically or hydraulically operated inflatable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/02Surgical instruments, devices or methods, e.g. tourniquets for holding wounds open; Tractors
    • A61B17/025Joint distractors
    • A61B2017/0256Joint distractors for the spine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00Anatomical parts of the body
    • A61M2210/02Bones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00Anatomical parts of the body
    • A61M2210/10Trunk
    • A61M2210/1003Spinal column
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M25/1011Multiple balloon catheters
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S606/00Surgery
    • Y10S606/907Composed of particular material or coated
    • Y10S606/91Polymer

Definitions

  • the invention relates to expandable structures, which, in use, are deployed in interior body regions of humans and other animals.
  • expandable structures generically called “balloons,” into cancellous bone
  • U.S. Pat. Nos. 4,969,888 and 5,106,404 disclose apparatus and methods using expandable structures in cancellous bone for the fixation of fractures or other osteoporotic and non-osteoporotic conditions of human and animal bones.
  • expandable structures When deployed in cancellous bone, expandable structures should undergo expansion and distention without failure. Furthermore, such structures, when distended, should generally match the geometry of the interior bone space in which the structure is deployed. In addition, such structures should allow preferential expansion to areas of lowest bone density. Exposure to cancellous bone also requires materials that exhibit superior resistance to surface abrasion and tensile stresses.
  • expandable structures made from an elastomer material e.g., polyurethane
  • a desired shape e.g., by exposure to heat and pressure
  • One aspect of the invention provides systems and methods comprising a first tool for establishing a percutaneous access path to a bone structure having cortical bone enclosing a cancellous bone volume and a a second tool comprising an expandable structure sized and configured to be inserted into the bone structure through the percutaneous access path.
  • the expandable structure comprises a wall made from a flexible material and includes an expandable region preformed with a normally expanded shape outside bone. The expandable region is expandable beyond its normally expanded shape to reach an inflation volume sized and configured to condition cortical bone for the receipt of a filler material.
  • the expandable region has a proximal expanded section, a distal expanded section, and an intermediate expanded section located between the proximal and distal expanded sections.
  • the intermediate expanded section has, when the wall is in the normally expanded shape and at the inflation volume, an average wall thickness greater than average wall thicknesses of either the first and second sections.
  • the systems and methods include a third tool to convey a filler material into the cancellous bone volume.
  • FIG. 1 is a coronal view of a vertebral body
  • FIG. 2 is a lateral view of the vertebral body shown in FIG. 1 ;
  • FIG. 3 is a plan view of a tool which carries at its distal end an expandable structure that embodies features of the invention
  • FIGS. 4A and 4B are enlarged side views of the expandable structure carried by the tool shown in FIG. 3 ;
  • FIG. 5 is a perspective end view of a tube made of a polyurethane or elastomer material prior to being formed into the expandable structure shown in FIG. 4A ;
  • FIG. 6 is a top perspective view of the tube shown in FIG. 5 positioned in a shape-forming fixture, of which parts are broken away to permit viewing its interior;
  • FIG. 7 is a top perspective view of the shape-forming fixture shown in FIG. 6 , in use applying heat and pressure to a region of the tube to form a shaped, expandable region;
  • FIG. 8 is a coronal view of the vertebral body shown in FIG. 1 , with the tool shown in FIG. 3 deployed to compress cancellous bone as a result of inflating the expandable structure;
  • FIG. 9 is a coronal view of the vertebral body shown in FIG. 8 , upon removal of the tool, showing the cavity formed by the compression of cancellous bone by the expandable structure;
  • FIG. 10 is a graph which plots the effects of increasing pressure applied to the interior of the structure to the expanded volume of the structure
  • FIG. 11 is a coronal view of the vertebral body shown in FIG. 8 , with the tool deployed to compress cancellous bone, and in which a bendable stylet alters the orientation of the expandable structure in cancellous bone;
  • FIG. 12 is a side view of a complex structure which includes several expandable segments spaced along its length;
  • FIG. 13 is a top perspective view of a shape-forming fixture used to apply pressure and heat to an extruded or molded tube to create the structure shown in FIG. 12 ;
  • FIG. 14 is a top view of a kit which holds the tool shown in FIG. 3 in a sealed, sterile environment prior to use;
  • FIG. 15 is an exploded view of the kit shown in FIG. 14 ;
  • FIG. 16 is a side view, partly in section, of a composite expandable structure.
  • the preferred embodiment describes improved systems and methods that embody features of the invention in the context of treating bones. This is because the new systems and methods are advantageous when used for this purpose. However, aspects of the invention can be advantageously applied for diagnostic or therapeutic purposes in other areas of the body.
  • FIG. 1 shows a coronal (top) view of a human lumbar vertebra 12 .
  • FIG. 2 shows a lateral (side) view of the vertebra.
  • the vertebra 12 includes a vertebral body 25 , which extends on the anterior (i.e., front or chest) side of the vertebra 12 .
  • the vertebral body 26 is shaped generally like a marshmallow.
  • the vertebral body 26 includes an exterior formed from compact cortical bone 28 .
  • the cortical bone 28 encloses an interior volume of reticulated cancellous, or spongy, bone 32 (also called medullary bone or trabecular bone).
  • the spinal canal 35 (see FIG. 1 ), is located on the posterior (i.e., back) side of each vertebra 12 .
  • the spinal cord (not shown) passes through the spinal canal 36 .
  • the vertebral arch 40 surrounds the spinal canal 35 .
  • Left and right pedicles 42 of the vertebral arch 40 adjoin the vertebral body 25 .
  • the spinous process 44 extends from the posterior of the vertebral arch 40 , as do the left and right transverse processes 46 .
  • cancellous bone may be indicated, due to disease or trauma, to compress cancellous bone within the vertebral body.
  • the compression for example, can be used to form an interior cavity, which receives a filling material, e.g., a flowable material that sets to a hardened condition, like bone cement, allograft tissue, autograft tissue, hydroxyapatite, or synthetic bone substitute, as well as a medication, or combinations thereof, to provide improved interior support for cortical bone or other therapeutic functions, or both.
  • a filling material e.g., a flowable material that sets to a hardened condition, like bone cement, allograft tissue, autograft tissue, hydroxyapatite, or synthetic bone substitute, as well as a medication, or combinations thereof.
  • the compaction of cancellous bone also exerts interior force upon cortical bone, making it possible to elevate or push broken and compressed bone back to or near its original prefracture, or other desired, condition.
  • FIG. 3 shows a tool 48 for accessing bone for the purpose of compacting cancellous bone.
  • the tool 48 includes a catheter tube 50 having a proximal end 52 and a distal end 54 .
  • the proximal end 52 carries a handle 14 to facilitate gripping and maneuvering the tube 50 .
  • the proximal end 52 also carries a fitting 122 to enable connection of the tool 48 to external equipment, as will be described later.
  • the distal end 54 of the tool 48 carries a structure 55 , which, in use, is intended to be expanded in cancellous bone, e.g., in the vertebral body 26 shown in FIGS. 1 and 2 .
  • the material from which the structure 56 is made should possess various physical and mechanical properties to optimize its functional capabilities to compact cancellous bone.
  • the three most important properties are the ability to expand its volume; the ability to deform in a desired way when expanding and assume a desired shape inside bone; and the ability to withstand abrasion, tearing, and puncture when in contact with cancellous bone.
  • a first desired property for the structure material is the ability to expand or otherwise increase its volume without failure. This property enables the structure 55 to be deployed in a collaD8ed, low profile condition subcutaneously, e.g., through a cannula, into the targeted bone region. This property also enables the expansion of the structure 56 inside the targeted bone region to press against and compress surrounding cancellous bone, or move cortical bone to a prefracture or other desired condition, or both.
  • the expansion property for the material can be characterized, e.g., by ultimate elongation properties, which indicate the greatest degree of expansion that the material can accommodate prior to failure.
  • An ultimate elongation of at least about 300% before material failure provides the ability to expand to the volume necessary to compact cancellous bone, as well as lift contiguous cortical bone.
  • a material with an ultimate elongation of less than about 300% is prone to exhibit failure at inflation volumes short of the desired bone compacting volume.
  • a second desired property for the material of the structure 56 is the ability to predictably deform during expansion, so that the structure 55 consistently achieves a desired shape inside bone.
  • the shape of the structure 55 when expanded in bone, is selected by the physician, taking into account the morphology and geometry of the site to be treated.
  • the shape of the cancellous bone to be compressed, and the local structures that could be harmed if bone were moved inappropriately, are generally understood by medical professionals using textbooks of human skeletal anatomy along with their knowledge of the site and its disease or injury, and also taking into account the teachings of U.S. patent application Ser. No. 08/788,785, filed Jan. 23, 1997, and entitled “Improved Inflatable Device for Use in Surgical Protocol Relating to Fixation of Bone,” which is incorporated herein by reference.
  • the physician is also able to select the desired expanded shape inside bone based upon prior analysis of the morphology of the targeted bone using, for example, plain film x-ray, fluoroscopic x-ray, or MRI or CT scanning.
  • the expanded shape inside bone is selected to optimize the formation of a cavity that, when filled with a selected material, provides support across the region of the bone being treated.
  • the selected expanded shape is made by evaluation of the predicted deformation that will occur with increased volume due to the shape and physiology of the targeted bone region.
  • the selection of the expanded shape of the structure 56 inside bone should take into account the cancellous bone volume which should be compacted to achieve the desired therapeutic result.
  • An exemplary range is about 30-06 to 90% of the cancellous bone volume, but the range can vary depending upon the targeted bone region. Generally speaking, compacting less of the cancellous bone volume leaves more uncompacted, diseased cancellous bone at the treatment site.
  • Another general guideline for the selection of the expanded shape of the structure 56 inside bone is the amount that the targeted fractured bone region has been displaced or depressed.
  • the controlled deformation diameter expansion of the structure 55 within the cancellous bone region inside a bone can elevate or push the fractured cortical wall back to or near its anatomic position occupied before fracture occurred.
  • inadequate compaction of cancellous bone results in less lifting of contiguous cortical bone.
  • the expanded shape of the structure 55 inside bone when in contact with cancellous bone, substantially conforms to the shape of the structure 56 outside bone, when in an open air environment. This allows the physician to select in an open air environment a structure having an expanded shape desired to meet the targeted therapeutic result, with the confidence that the expanded shape inside bone will be similar in important respects.
  • An optimal degree of shaping can be achieved by material selection and by special manufacturing techniques, e.g., thermoforming or blow molding, as will be described in greater detail later.
  • a third desired property for the material of the structure 56 is the ability to resist surface abrasion, tearing, and puncture when in contact with cancellous bone.
  • a Taber Abrasion Resistance Value of less than about 90 mg loss indicates resistance to puncture when contacting cancellous bone.
  • a Rotating Drum Abrasion Resistance Value of less than 70 mm3 also indicates resistance to puncture when contacting cancellous bone.
  • This property can further be characterized, e.g., by an Elmendorf tear strength of greater than about 280 lbf/in, which indicates resistance to failure caused by cancellous bone abrasion.
  • This property can also be characterized, e.g., by a Shore Hardness value of less than about 100 A. This value indicates a degree of elasticity, flexibility, and ductility.
  • the expansion and shape properties just described can be enhanced and further optimized for compacting cancellous bone by selecting an elastomer material, which also possess the capability of being preformed, i.e., to acquire a desired shape by exposure, e.g., to heat and pressure, e.g., through the use of conventional thermoforming or blow molding techniques.
  • elastomer material which also possess the capability of being preformed, i.e., to acquire a desired shape by exposure, e.g., to heat and pressure, e.g., through the use of conventional thermoforming or blow molding techniques.
  • e materials that meet this criteria include polyurethane, silicone, thermoplastic rubber, nylon, and thermoplastic elastomer materials. In a most preferred embodiment, polyurethane material is used.
  • the structure 55 comprises an elongated tube 16 made from a polyurethane material.
  • the tube 15 possesses end regions 18 and 20 , each having a first diameter (designated D 1 in FIG. 4A ).
  • the tube 16 further includes an intermediate preformed region 22 .
  • the diameter of the preformed intermediate region 22 has been enlarged by exposure to heat and pressure to a normally expanded shape having an enlarged diameter (designated D 3 in FIG. 4A ) greater than the first diameter D 1 .
  • the normally expanded shape D 3 exists in an open air environment, prior to placement inside an interior body region.
  • the tube 16 is initially formed from polyurethane (or another preferred) material, for example, by standard polymer extrusion and molding processes.
  • the shaped region 22 is created by exposing the region 22 to heat within a fixture or mold 10 , while positive interior pressure is applied to the tube 15 within the region 22 .
  • the fixture 10 includes a cavity 24 , in which the region 22 rests while heat and pressure are applied.
  • the cavity 24 has a geometry that the region 22 is intended to assume when inflated with interior pressure in the fixture 10 . In the illustrated embodiment, a generally spherical shape is envisioned.
  • the heat can be applied by coupling the cavity 24 to a source 120 of heat energy of the fixture 10 itself (as FIG. 7 shows), or conveying a hot air stream or the equivalent into the cavity 24 .
  • the temperature selected is that at which the tube material will soften and form.
  • the range of temperatures in which softening occurs will depend upon the particular composition of the polymeric material used. For example, for polyurethane, the softening temperature lays in the range of about 50° C. to about 190° C. An operating range of softening temperatures for a given plastic material can be empirically determined.
  • FIG. 7 shows, while in a heat-softened state and confined within the cavity 24 , one end region 18 is coupled to a source 34 of pressurized fluid.
  • the other end region 20 not coupled to the source 34 is closed with a cap 122 or otherwise blocked to retain pressurized fluid in the tube 16 .
  • the pressurized fluid is air or an inert gas, designated A in FIG. 7 .
  • the magnitude of pressure will vary depending upon the wall thickness and other physical characteristics of the elastomer material used.
  • the pressure must be less than the burst strength of the tube material.
  • air pressure in the range of 5 to 1000 D8i can be used.
  • the introduction of pressurized air A into the tube 16 causes the heat-softened region 22 to expand or billow outwardly in the cavity 24 , as FIG. 7 shows.
  • the cavity 24 limits the extent to which the heat-softened region 22 can expand.
  • the region 22 will, upon expansion, conform to the geometry of the cavity 24 .
  • the extension of the heat-softened material in the cavity 24 uniformly relieves material stress in the region 22 , as the region 22 acquires a new expanded shape, having the enlarged diameter D 3 shown in FIG. 4A .
  • the application of heat is terminated, and the region 22 is allowed to cool, while pressurized fluid is applied to maintain the enlarged diameter D 3 .
  • the region 22 can be cooled by an ambient external air flow, or by a pressurized stream of cooling air.
  • the cavity 24 can include interior passages through which a cooling fluid can be circulated. The speed at which cooling occurs affects the time of the overall process.
  • the normally expanded shape characteristics of the structure 55 can be achieved by other techniques.
  • the structure 56 can be formed by dipping, lost wax casting, or injection molding.
  • the structure of the catheter tube 50 can vary and is not critical to the invention per se.
  • the materials for the catheter tube 50 are selected to facilitate advancement of the structure 55 into an interior body region.
  • the catheter tube 50 can be constructed, for example, using standard flexible, medical grade plastic materials, like vinyl, nylon, polyethylenes, ionomer, polyurethane, and polyethylene tetraphthalate (PET).
  • PET polyethylene tetraphthalate
  • the catheter tube 50 can also include more rigid materials to impart greater stiffness and thereby aid in its manipulation. More rigid materials that can be used for this purpose include KevlarTM material, PEBAXTM material, stainless steel, nickel-titanium alloys (NitinolTM material), and other metal alloys.
  • the catheter tube 50 includes an interior bore 50 , in which an auxiliary tube 58 is secured.
  • the catheter tube 50 can have more than a single interior lumen, and can, e.g., have an array of multiple lumens.
  • the auxiliary tube 58 extends through the interior bore 60 and beyond the distal end 54 of the catheter tube 50 .
  • One end region 18 of the tube 16 is secured to the distal end 54 of the catheter tube 50
  • the other end region 20 is secured to the free extended end 62 of the auxiliary tube 58 .
  • the end regions 18 and 20 can be secured, e.g., using adhesive or thermal bonding processes.
  • the structure 56 By drawing a vacuum (i.e., negative pressure) inside the structure 56 , resident air volume is removed, and the diameter of the region 22 is diminished from its normally expanded shape D 3 to a substantially collaD8ed, and not inflated diameter D 2 .
  • the collaD8ed diameter D 2 is, due to forming during the heat and pressure shaping process, still different than the extruded or molded diameter D 1 .
  • the structure 56 When substantially collaD8ed or not inflated, the structure 56 exhibits a low profile, ideal for insertion into the targeted cancellous bone region. The low profile can be further reduced to aid insertion, if desired, by enclosing the structure 56 within a constricted introducing sleeve, or by coating the structure 56 with a lubricious material, such as silicone, or both.
  • the interior bore 60 of the catheter tube 50 can be coupled (via the fitting 122 ) to a source 68 of fluid, for example, sterile saline, or a radiopaque contrast medium, which permits x-ray visualization of the structure 56 .
  • the interior bore 60 conveys the fluid into the region 22 .
  • the increase of volume within the region up to a given threshold amount (designated V(D 3 ) in FIG. 10 ) will return the intermediate region 22 from the collaD8ed diameter D 2 to the normal (i.e., enlarged, but not distended) geometry, having the shape and diameter D 3 .
  • the magnitude of the radius of expansion depends upon the relative increase in diameter in the region 22 brought about by exposure to heat and interior pressure within the cavity 24 .
  • the relative increase between the extruded or molded tube diameter D 1 and diameter D 3 should be at least 5% to provide tube length and geometry of the segment when it expands beyond diameter D 3 .
  • the wall thickness of the structure 56 is not uniform.
  • the region 22 has a minimum wall thickness T 3 when in its normally enlarged diameter D 3 , which is less than the normal extruded or molded wall thickness (T 1 ) of the tube 86 .
  • the threshold pressure P(t) stays generally constant as volume increases between D 3 and D 4 . As long as volume is controlled (i.e., so as not to substantially exceed D 4 ), there is no need for an external pressure regulator. Volume expansion between D 3 and D 4 at a substantially constant pressure occurs because of the material properties of the structure 56 , and not because of some external pressure control mechanism.
  • the wall thickness T 4 at the distended geometry D 4 is less than the minimum wall thickness T 3 of the normally enlarged diameter D 3 .
  • the distended geometry generally maintains the preformed shape dictated by the cavity 24 (which, in the illustrated embodiment, is spherical).
  • the structure 56 While expanding in the region between D 3 and D 4 , the structure 56 , when inside bone, assumes an increasingly larger surface and volume, thereby compacting surrounding cancellous bone. Inflation in cancellous bone may occur at the same threshold pressure P(t) as outside bone. However, an increase in the threshold inflation pressure P(t) inside bone may be required, due to the density of the cancellous bone and resistance of the cancellous bone to compaction. In this instance, the configuration of the Pressure vs. Volume curve for a given material and structure 56 remains essentially the same as shown in FIG. 10 , except that the generally horizontal portion of the curve between D 3 and D 4 is shifted upward on the Y-axis, as shown in phantom lines in FIG. 10 . As a general statement, the threshold pressure inside bone is determined by the material property of the structure 56 and any added resistance due to the presence of cancellous bone.
  • the distance between D 3 and D 4 , along the x-axis of FIG. 10 defines the degree to which the wall can elongate at a substantially constant pressure condition and with increasing material stress to compact cancellous bone, without failure.
  • wall failure becomes more likely as the diameter of the structure enlarges significantly further beyond the distended diameter D 4 .
  • the structure 56 can no longer increase its volume as the material elasticity approaches ultimate elongation, or as material stress approaches ultimate tensile strength. When either of these ultimate values are reached, wall failure is likely.
  • the distance between D 3 and D 4 in FIG. 10 during expansion inside bone is a simultaneous expression of the three physical and mechanical properties—expansion, shape, and toughness—described above.
  • FIG. 12 shows a complex preformed structure 80 includes segmented expandable regions 82 and 84 spaced along its length.
  • the structure 80 provides a longer profile along which volume can be increased.
  • the complex expandable structure 80 is created by extruding or molding a tube 86 of polyurethane or elastomer material, like the tube 16 shown in FIG. 5 .
  • the tube 86 is made of a polyurethane material.
  • the tube has a normal extruded wall thickness (T 5 ) and a normal extruded outside diameter (D 5 ) (as shown in FIG. 12 ).
  • the segmented shaped regions 82 and 84 are created by exposing an intermediate region 88 of the tube 86 to heat and positive interior pressure inside a fixture or mold 90 , as shown in FIG. 13 .
  • the fixture 90 possesses two cavity regions 92 and 94 with an intermediate channel 96 .
  • the intermediate region 88 is located in the cavities 92 and 94 and channel 96 .
  • the cavity regions 92 and 94 and the channel 95 are exposed to a source of heat 120 , to soften the material of the region 88 .
  • a source of heat 120 to soften the material of the region 88 .
  • the interior of the tube 86 is subjected to positive pressure from a source 34 (as also previously described).
  • the material in the region 88 expands or extends within the cavities 92 and 94 and the channel 96
  • the structure 80 can be attached to the distal end of a catheter tube 50 in the same fashion as the structure 56 shown in FIGS. 3 and 4 .
  • the structure 80 possesses, in an open air environment, a normal expanded shape, having diameter D 7 (shown in phantom lines in FIG. 12 ).
  • the normal shape and diameter D 7 for the regions 82 and 84 generally correspond with the shape and dimension of the cavities 92 and 94 , respectively.
  • the structure 80 When an interior vacuum is drawn, removing air from the structure 80 , the structure 80 assumes a substantially collaD8ed, and not inflated geometry, shown in phantom lines D 6 in FIG. 12 . Due to the application of heat and pressure upon the region 88 , diameter D 6 for each region 82 and 84 is larger than the normal extruded or molded outside diameter D 5 of the original extruded tube 86 .
  • the regions 82 and 84 are separated by a tubular neck 98 , which segments the structure 80 into two expandable regions 82 and 84 .
  • the structure 80 When substantially collaD8ed under vacuum or not inflated, the structure 80 exhibits a low profile, ideal for insertion into the targeted cancellous bone region.
  • each region 82 and 84 will return from the collapsed diameter D 5 back to the normal, enlarged, but not distended geometry, having the shape and diameter shown in phantom lines D 7 in FIG. 12 .
  • the first and second shaped regions 82 and 84 have generally the same radius of expansion and thus the same non-distended shape and diameter D 7 .
  • each region 82 and 84 can have a different radius of expansion, and thus a different non-distended shape and diameter.
  • the material of the structure 80 in the region 88 is not significantly stretched or stressed, because the regions 82 and 84 have been previously expanded in a stress-relieved condition into this geometry in the cavities 92 and 94 .
  • the regions 82 and 84 can be shaped by heat and interior pressure within different cavities to assume different geometries, e.g., cylindrical or elliptical geometry, or a non-spherical, non-cylindrical, or non-elliptical geometry, with either uniform or complex curvature, and in either symmetric or asymmetric forms.
  • different geometries e.g., cylindrical or elliptical geometry, or a non-spherical, non-cylindrical, or non-elliptical geometry, with either uniform or complex curvature, and in either symmetric or asymmetric forms.
  • more than two segmented regions 82 and 84 can be formed along the length of the tube 86 .
  • Each shaped region 82 and 84 possesses a minimum wall thickness (designed T 7 in FIG. 12 ) when in the normally enlarged but not distended geometry D 7 . Due to expansion of heat-softened material under pressure in the cavities 92 and 94 , the wall thickness is not uniform, i.e., T 7 is less than the normal extruded or molded wall thickness T 5 of the tube 85 .
  • the minimum wall thicknesses T 7 for the regions 82 and 84 can be the same or different.
  • the neck region 98 When in the enlarged, but not distended geometry, the neck region 98 has an outside diameter (designated D 9 in FIG. 14 ), which is equal to or greater than the normal extruded or molded diameter D 5 of the tube 86 .
  • the size of the channel 96 in the fixture 90 determines the magnitude of the diameter D 9 .
  • the neck region 98 Due to expansion of heat-softened material in the adjacent regions 82 and 84 under pressure in the cavities 92 and 94 , the neck region 98 (which expands under pressure in the channel 96 ) has a wall thickness (designated T 9 in FIG. 12 ) which is less than or equal to the normal extruded or molded wall thickness TE of the tube 86 , but still greater than the minimum wall thickness T 7 of either fully shaped region 82 or 84 .
  • the formed complex structure 80 thus possesses regions of non-uniform minimum wall thickness along its length; that is, T 5 ⁇ T 9 >T 7 .
  • the formed complex structure 80 also provides multiple expandable regions 82 and 84 of the same or different enlarged outside diameters (D 7 ), segmented by a neck region 98 , in which D 6 >D 5 ; D 7 >D 6 ; and D 7 >D 9 .
  • the shaped regions 82 and 84 of the structure 80 will continue to enlarge beyond diameter D 7 to a distended shape and geometry, designated D 8 in FIG. 12 .
  • the wall thickness T 7 further decreases and approaches T 8 .
  • the diameter D 9 of the neck region 98 will likewise increase toward diameter D 10 , as FIG. 12 shows, providing more-uniform, elongated surface contact with cancellous bone.
  • Enlargement of the structure 80 beyond diameter D 7 stretches the material in the regions 82 , 84 , and 98 beyond their stress-relieved condition, although the distended geometry of the regions 82 and 84 will, in important respects, maintain the preformed shape dictated by the cavities 92 and 94 .
  • the material in the regions 82 and 84 has already been stress-relieved in the desired shape at the normal diameter D 7 .
  • enlargement toward the distended diameter D 8 occurs at substantially constant pressure (as FIG. 10 exemplifies), and at increasing material stress.
  • the degree of stretching at a substantially constant incremental pressure condition can be tailored to achieve a desired, fully distended diameter D 8 .
  • the final, fully distended diameter D 8 can be selected to match the dimensions of the targeted cancellous bone region.
  • the controlled stretching of the segmented regions 82 and 84 in tandem can provide an equal volume compression of cancellous bone with a major diameter that is less than a single non-segmented region (i.e., one without the neck region 98 ). Stated another way, segmented regions 82 and 84 , when expanded to a given inflation volume, have a diameter less than a sphere expanded to an equal inflation volume.
  • the structure 80 While expanding in the region between D 7 and D 8 , the structure 80 , like the structure 56 , when inside bone, assumes an increasingly larger surface and volume, thereby compacting surrounding cancellous bone. Inflation in cancellous bone may occur at the same threshold pressure P(t) as outside bone. However, an increase in the threshold inflation pressure P(t) inside bone may be required, due to the density of the cancellous bone and resistance of the cancellous bone to compaction.
  • the material of the structure 56 or 80 is selected to integrate all desired physical and mechanical requirements of expansion, shape, and toughness.
  • FIG. 16 exemplifies a composite expandable structure 130 , in which the desired physical and mechanical requirements are segregated by the use of different materials.
  • the composite structure 130 includes an inner expandable body 132 made of a first material that meets one or more of the desired requirements of expansion and shape.
  • the composite structure 130 includes an outer expandable body or shell 134 , which is made of a second material that meets the desired requirement of toughness.
  • the shell 134 encaD8ulates and protects the inner expandable body 132 from surface abrasion, tearing, or puncture due to contact with cancellous bone.
  • the shell 134 can comprise a material applied to the surface of the inner body by various dipping, painting, or coating techniques. Alternatively, the shell 134 can comprise a bag or sock, into which the inner body 132 is placed prior to deployment.
  • the material for the shell 134 can comprise, e.g., rubber, silicone, ethylene vinyl acetate, polyurethane, polyethylene, or multi-filament woven material or fabric or other polymer material.
  • the composite structure 130 makes it possible to isolate the expansion and shape requirements from the toughness requirement
  • a material completely or partially failing to meet the toughness requirement can nevertheless be used for the inner body 132 to optimize the expansion and shape requirements of the structure 130 .
  • the inner body 132 imparts its optimized expansion and shape characteristics to cancellous bone, while the shell 134 imparts its Optimized toughness characteristic to the overall composite structure 130 .
  • the structure 56 or 80 or 130 can be inserted into bone in accordance with the teachings of U.S. Pat. Nos. 4,969,888 and 5,108,404, which are incorporated herein by reference.
  • access can be accomplished, for example, by drilling an access portal 64 through a side of the vertebral body 25 . This is called a postero-lateral approach.
  • the access portal can pass through either pedicle 42 , which called a transpedicular approach.
  • the catheter tube 50 is advanced through the cannula 65 to deploy the structure ( FIG. 8 shows structure 55 ) into contact with cancellous bone 32 .
  • the structure 56 is in its normally collapsed and not inflated condition (shown as phantom line diameter D 2 in FIG. 8 ) during deployment. Access in this fashion can be accomplished using a closed, minimally invasive procedure or with an open procedure.
  • the materials for the catheter tube 50 are selected to facilitate advancement of the expandable structure 56 into cancellous bone 32 .
  • the catheter tube 50 can be constructed, for example, using standard flexible, medical grade plastic materials, like vinyl, nylon, polyethylenes, ionomer, polyurethane, and polyethylene tetraphthalate (PET).
  • PET polyethylene tetraphthalate
  • the catheter tube 50 can also include more rigid materials to impart greater stiffness and thereby aid in its manipulation. More rigid materials that can be used for this purpose include stainless steel, nickel-titanium alloys (NitinolTM material), and other metal alloys.
  • FIG. 8 shows, expansion of the structure 56 to its enlarged but not distended geometry (phantom line diameter D 3 in FIG. 8 ), and ultimately to its maximum distended geometry (diameter D 4 in FIG. 8 ) sequentially compresses cancellous bone 32 in the vertebral body 26 .
  • the compression forms an interior cavity 70 in the cancellous bone 32 .
  • FIG. 9 shows, subsequent collaD8e and removal of the structure 56 leaves the cavity 70 in a condition to receive a filling material, e.g., bone cement.
  • the bone cement when hardened, provides improved interior structural support for cortical bone 32 .
  • the compaction of cancellous bone 32 shown in FIG. 8 also exerts interior force upon the surrounding cortical bone 28 .
  • the interior force can elevate or push broken and compressed bone back to or near its original prefracture, or other desired, condition.
  • deterioration of cancellous bone 32 can cause the top and bottom plates (designated TP and BP in FIG. 2 ) to compress or move closed together, reducing the normal physiological height between the plates TP and BP.
  • the interior force exerted by the structure 56 as it compacts cancellous bone 32 moves one or both of the top and bottom plates TP and BP farther apart, to thereby restore a spacing between them, which is at or close to the normal physiological distance.
  • a stiffening member or stylet 74 can be inserted through a lumen 72 of the auxiliary tube 58 , which is enclosed within the structure 56 .
  • the stylet 74 can be made, e.g., from stainless steel or molded plastic material. The presence of the stylet 74 serves to keep the structure 55 in the desired distally straightened condition during passage through the guide sheath 66 into the targeted bone region, as FIG. 8 shows.
  • the stylet 74 can have a preformed memory, to normally bend its distal region.
  • the memory is overcome to straighten the stylet 14 when confined within the guide sheath 56 .
  • the preformed memory bends the stylet 74 .
  • the bending stylet 74 bends the auxiliary tube 58 and thereby shifts the main axis 78 of the surrounding expandable structure 56 relative to the axis 78 of the access path (i.e., the guide sheath 66 ).
  • the prebent stylet 74 positioned within the interior of the structure 56 , aids in altering the orientation of the structure 56 within targeted region. It is thereby possible to orient the structure 56 in a more generally aligned relationship with the natural axes of the vertebral body 25 .
  • a cavity 70 more centrally located within the bone, e.g., a vertebral body 26 , can be established, which provides more uniform support across the mid region of the vertebral body 26 when filled with bone cement. The capability of the vertebral body 26 to withstand loads is thereby enhanced.
  • the symmetric compaction of cancellous bone 32 in the interior volume also exerts more equal and uniform interior forces upon cortical bone 32 , to elevate or push broken and compressed bone.
  • an expandable structure 56 or 80 or 130 can compact a smaller volume of total bone. This is because the diseased area requiring treatment is smaller.
  • an expandable structure 56 or 80 or 130 to improve insertion of solid materials in defined shapes, like hydroxyapatite and components in total joint replacement.
  • the structure shape and size is defined by the shape and size of the material being inserted.
  • the cancellous bone may or may not be diseased or adversely affected. Healthy cancellous bone can be sacrificed by significant compaction to improve the delivery of a drug or growth factor which has an important therapeutic purpose.
  • the size of the expandable structure 55 or 80 or 130 is chosen by the desired amount of therapeutic substance sought to be delivered.
  • the bone with the drug inside may need to be supported by standard methods while the drug works and the bone heals.
  • Distention of any one of the expandable structures 56 or 80 or 130 described herein during first use in a targeted body region generates stress on the material or materials which make up the structure.
  • the material stress created by operational loads during first use in a targeted body region can significantly alter the preformed morphology of the structure, making future performance of the structure unpredictable.
  • expansion within bone during a single use creates contact with surrounding cortical and cancellous bone. Regardless of the superior mechanical properties of material, this contact can in time damage the structure, creating localized regions of weakness, which may escape detection. Localized areas of lower density cancellous bone may result in creating areas of differential expansion and stress on the structure. The existence of localized regions of weakness or differential stress can unpredictably cause overall structural failure during a subsequent use.
  • the invention also provides a kit 100 (see FIGS. 14 and 15 ) for storing a single use tool 48 (also shown in FIG. 3 ) prior to use.
  • the tool 48 carries an expandable structure.
  • FIG. 14 shows for the purpose of illustration the structure 56 , as described herein. It should be appreciated that the tool 48 could carry an expandable structure 80 or 130 , as also previously described.
  • the kit 100 includes an interior tray 108 .
  • the tray 108 holds the tool 48 in a lay-flat, straightened condition during sterilization and storage prior to its first use.
  • the tray 108 can be formed from die cut cardboard or thermoformed plastic material.
  • the tray 108 includes one or more spaced apart tabs 110 , which hold the catheter tube 50 and expandable structure 55 in the desired lay-flat, straightened condition.
  • the kit 100 includes an inner wrap 112 , which is peripherally sealed by heat or the like, to enclose the tray 108 from contact with the outside environment.
  • One end of the inner wrap 112 includes a conventional peal-away seal 114 , to provide quick access to the tray 108 upon instance of use, which preferably occurs in a sterile environment, such as within an operating room.
  • the kit 100 also includes an outer wrap 116 , which is also peripherally sealed by heat or the like, to enclosed the inner wrap 112 .
  • One end of the outer wrap 116 includes a conventional peal-away seal 118 , to provide access to the inner wrap 112 , which can be removed from the outer wrap 116 in anticipation of imminent use of the probe 102 , without compromising sterility of the probe 102 itself.
  • Both inner and outer wraps 112 and 116 each includes a peripherally sealed top sheet 120 and bottom sheet 122 .
  • the top sheet 120 is made of transparent plastic film, like polyethylene or MYLARTM material, to allow visual identification of the contents of the kit 100 .
  • the bottom sheet 122 is made from a material that is permeable to ETO sterilization gas, e.g., TYVEKTM plastic material (available from Dupont).
  • the sterile kit 100 also carries a label or insert 106 , which includes the statement “For Single Patient Use Only” (or comparable language) to affirmatively caution against reuse of the contents of the kit 100 .
  • the label 106 also preferably affirmatively instructs against resterilization of the tool 48 .
  • the label 105 also preferably instructs the physician or user to dispose of the tool 48 and the entire contents of the kit 100 upon use in accordance with applicable biological waste procedures.
  • the presence of the probe 102 packaged in the kit 100 verifies to the physician or user that tool 48 is sterile and has not been subjected to prior use. The physician or user is thereby assured that the expandable structure 55 meets established performance and sterility specifications, and will have the desired configuration when expanded for use.
  • the label 106 preferably also instructs the physician as to the use of the expandable structure 56 (or 80 or 130) for compacting cancellous bone in the manners previously described.
  • the label 105 instructs the physician to expand the structure inside bone to compact cancellous bone and form a cavity.
  • the label 106 can also instruct the physician to fill the cavity with a material, e.g., bone cement, allograft material, synthetic bone substitute, a medication, or a flowable material that sets to a hardened condition.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Surgery (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Medical Informatics (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Surgical Instruments (AREA)
  • Laminated Bodies (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
  • Investigation Of Foundation Soil And Reinforcement Of Foundation Soil By Compacting Or Drainage (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)

Abstract

An expandable structure made from an elastomer material is preformed to a desired geometry by exposure to heat and pressure. The structure undergoes controlled expansion and further distention in cancellous bone, with controlled deformation and without stress failure.

Description

    RELATED APPLICATIONS
  • This application is a divisional of co-pending application Ser. No. 11/299,172, filed Dec. 9, 2005, which is a divisional of application Ser. No. 09/837,350, filed Apr. 18, 2001, which is a continuation of application Ser. No. 09/088,459, filed Jun. 1, 1998 (now abandoned), which claims the benefit of application Ser. No. 08/788,786, filed Jan. 23, 1997 (now U.S. Pat. No. 6,235,043), which is a continuation of application Ser. No. 08/188,224, filed Jan. 26, 1994 (now abandoned).
  • FIELD OF THE INVENTION
  • The invention relates to expandable structures, which, in use, are deployed in interior body regions of humans and other animals.
  • BACKGROUND OF THE INVENTION
  • The deployment of expandable structures, generically called “balloons,” into cancellous bone is known. For example, U.S. Pat. Nos. 4,969,888 and 5,106,404 disclose apparatus and methods using expandable structures in cancellous bone for the fixation of fractures or other osteoporotic and non-osteoporotic conditions of human and animal bones.
  • SUMMARY OF THE INVENTION
  • When deployed in cancellous bone, expandable structures should undergo expansion and distention without failure. Furthermore, such structures, when distended, should generally match the geometry of the interior bone space in which the structure is deployed. In addition, such structures should allow preferential expansion to areas of lowest bone density. Exposure to cancellous bone also requires materials that exhibit superior resistance to surface abrasion and tensile stresses.
  • It is has been discovered that expandable structures made from an elastomer material, e.g., polyurethane, which have been preformed to a desired shape, e.g., by exposure to heat and pressure, can undergo controlled expansion and further distention in cancellous bone, without failure, while exhibiting superior resistance to surface abrasion and puncture when contacting cancellous bone.
  • One aspect of the invention provides systems and methods comprising a first tool for establishing a percutaneous access path to a bone structure having cortical bone enclosing a cancellous bone volume and a a second tool comprising an expandable structure sized and configured to be inserted into the bone structure through the percutaneous access path. The expandable structure comprises a wall made from a flexible material and includes an expandable region preformed with a normally expanded shape outside bone. The expandable region is expandable beyond its normally expanded shape to reach an inflation volume sized and configured to condition cortical bone for the receipt of a filler material. The expandable region has a proximal expanded section, a distal expanded section, and an intermediate expanded section located between the proximal and distal expanded sections. The intermediate expanded section has, when the wall is in the normally expanded shape and at the inflation volume, an average wall thickness greater than average wall thicknesses of either the first and second sections. The systems and methods include a third tool to convey a filler material into the cancellous bone volume.
  • Features and advantages of the inventions are set forth in the following Description and Drawings, as well as in the appended Claims.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a coronal view of a vertebral body;
  • FIG. 2 is a lateral view of the vertebral body shown in FIG. 1;
  • FIG. 3 is a plan view of a tool which carries at its distal end an expandable structure that embodies features of the invention;
  • FIGS. 4A and 4B are enlarged side views of the expandable structure carried by the tool shown in FIG. 3;
  • FIG. 5 is a perspective end view of a tube made of a polyurethane or elastomer material prior to being formed into the expandable structure shown in FIG. 4A;
  • FIG. 6 is a top perspective view of the tube shown in FIG. 5 positioned in a shape-forming fixture, of which parts are broken away to permit viewing its interior;
  • FIG. 7 is a top perspective view of the shape-forming fixture shown in FIG. 6, in use applying heat and pressure to a region of the tube to form a shaped, expandable region;
  • FIG. 8 is a coronal view of the vertebral body shown in FIG. 1, with the tool shown in FIG. 3 deployed to compress cancellous bone as a result of inflating the expandable structure;
  • FIG. 9 is a coronal view of the vertebral body shown in FIG. 8, upon removal of the tool, showing the cavity formed by the compression of cancellous bone by the expandable structure;
  • FIG. 10 is a graph which plots the effects of increasing pressure applied to the interior of the structure to the expanded volume of the structure;
  • FIG. 11 is a coronal view of the vertebral body shown in FIG. 8, with the tool deployed to compress cancellous bone, and in which a bendable stylet alters the orientation of the expandable structure in cancellous bone;
  • FIG. 12 is a side view of a complex structure which includes several expandable segments spaced along its length;
  • FIG. 13 is a top perspective view of a shape-forming fixture used to apply pressure and heat to an extruded or molded tube to create the structure shown in FIG. 12;
  • FIG. 14 is a top view of a kit which holds the tool shown in FIG. 3 in a sealed, sterile environment prior to use;
  • FIG. 15 is an exploded view of the kit shown in FIG. 14; and
  • FIG. 16 is a side view, partly in section, of a composite expandable structure.
  • The invention may be embodied in several forms without departing from its spirit or essential characteristics. The scope of the invention is defined in the appended claims, rather than in the specific description preceding them. All embodiments that fall within the meaning and range of equivalency of the claims are therefore intended to be embraced by the claims.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • The preferred embodiment describes improved systems and methods that embody features of the invention in the context of treating bones. This is because the new systems and methods are advantageous when used for this purpose. However, aspects of the invention can be advantageously applied for diagnostic or therapeutic purposes in other areas of the body.
  • The new systems and methods will be more specifically described in the context of the treatment of human vertebra. Of course, other human or animal bone types can be treated in the same or equivalent fashion.
  • FIG. 1 shows a coronal (top) view of a human lumbar vertebra 12. FIG. 2 shows a lateral (side) view of the vertebra. The vertebra 12 includes a vertebral body 25, which extends on the anterior (i.e., front or chest) side of the vertebra 12. The vertebral body 26 is shaped generally like a marshmallow.
  • As FIGS. 1 and 2 show, the vertebral body 26 includes an exterior formed from compact cortical bone 28. The cortical bone 28 encloses an interior volume of reticulated cancellous, or spongy, bone 32 (also called medullary bone or trabecular bone).
  • The spinal canal 35 (see FIG. 1), is located on the posterior (i.e., back) side of each vertebra 12. The spinal cord (not shown) passes through the spinal canal 36. The vertebral arch 40 surrounds the spinal canal 35. Left and right pedicles 42 of the vertebral arch 40 adjoin the vertebral body 25. The spinous process 44 extends from the posterior of the vertebral arch 40, as do the left and right transverse processes 46.
  • It may be indicated, due to disease or trauma, to compress cancellous bone within the vertebral body. The compression, for example, can be used to form an interior cavity, which receives a filling material, e.g., a flowable material that sets to a hardened condition, like bone cement, allograft tissue, autograft tissue, hydroxyapatite, or synthetic bone substitute, as well as a medication, or combinations thereof, to provide improved interior support for cortical bone or other therapeutic functions, or both. The compaction of cancellous bone also exerts interior force upon cortical bone, making it possible to elevate or push broken and compressed bone back to or near its original prefracture, or other desired, condition.
  • I. Preformed Expandable Structures
  • FIG. 3 shows a tool 48 for accessing bone for the purpose of compacting cancellous bone. The tool 48 includes a catheter tube 50 having a proximal end 52 and a distal end 54. The proximal end 52 carries a handle 14 to facilitate gripping and maneuvering the tube 50. The proximal end 52 also carries a fitting 122 to enable connection of the tool 48 to external equipment, as will be described later. The distal end 54 of the tool 48 carries a structure 55, which, in use, is intended to be expanded in cancellous bone, e.g., in the vertebral body 26 shown in FIGS. 1 and 2.
  • A. Desired Physical and Mechanical Properties
  • The material from which the structure 56 is made should possess various physical and mechanical properties to optimize its functional capabilities to compact cancellous bone. The three most important properties are the ability to expand its volume; the ability to deform in a desired way when expanding and assume a desired shape inside bone; and the ability to withstand abrasion, tearing, and puncture when in contact with cancellous bone.
  • 1. Expansion Property
  • A first desired property for the structure material is the ability to expand or otherwise increase its volume without failure. This property enables the structure 55 to be deployed in a collaD8ed, low profile condition subcutaneously, e.g., through a cannula, into the targeted bone region. This property also enables the expansion of the structure 56 inside the targeted bone region to press against and compress surrounding cancellous bone, or move cortical bone to a prefracture or other desired condition, or both.
  • The expansion property for the material can be characterized, e.g., by ultimate elongation properties, which indicate the greatest degree of expansion that the material can accommodate prior to failure. An ultimate elongation of at least about 300% before material failure provides the ability to expand to the volume necessary to compact cancellous bone, as well as lift contiguous cortical bone. A material with an ultimate elongation of less than about 300% is prone to exhibit failure at inflation volumes short of the desired bone compacting volume.
  • 2. Shape Property
  • A second desired property for the material of the structure 56 is the ability to predictably deform during expansion, so that the structure 55 consistently achieves a desired shape inside bone.
  • The shape of the structure 55, when expanded in bone, is selected by the physician, taking into account the morphology and geometry of the site to be treated. The shape of the cancellous bone to be compressed, and the local structures that could be harmed if bone were moved inappropriately, are generally understood by medical professionals using textbooks of human skeletal anatomy along with their knowledge of the site and its disease or injury, and also taking into account the teachings of U.S. patent application Ser. No. 08/788,785, filed Jan. 23, 1997, and entitled “Improved Inflatable Device for Use in Surgical Protocol Relating to Fixation of Bone,” which is incorporated herein by reference. The physician is also able to select the desired expanded shape inside bone based upon prior analysis of the morphology of the targeted bone using, for example, plain film x-ray, fluoroscopic x-ray, or MRI or CT scanning. The expanded shape inside bone is selected to optimize the formation of a cavity that, when filled with a selected material, provides support across the region of the bone being treated. The selected expanded shape is made by evaluation of the predicted deformation that will occur with increased volume due to the shape and physiology of the targeted bone region.
  • In some instances, it is desirable, when creating a cavity, to also move or displace the cortical bone to achieve the desired therapeutic result. Such movement is not per se harmful, as that term is used in this Specification, because it is indicated to achieve the desired therapeutic result. By definition, harm results when expansion of the structure 55 results in a worsening of the overall condition of the bone and surrounding anatomic structures, for example, by injury to surrounding tissue or causing a permanent adverse change in bone biomechanics.
  • As one general consideration, in cases where the bone disease causing fracture (or the risk of fracture) is the loss of cancellous bone mass (as in osteoporosis), the selection of the expanded shape of the structure 56 inside bone should take into account the cancellous bone volume which should be compacted to achieve the desired therapeutic result. An exemplary range is about 30-06 to 90% of the cancellous bone volume, but the range can vary depending upon the targeted bone region. Generally speaking, compacting less of the cancellous bone volume leaves more uncompacted, diseased cancellous bone at the treatment site.
  • Another general guideline for the selection of the expanded shape of the structure 56 inside bone is the amount that the targeted fractured bone region has been displaced or depressed. The controlled deformation diameter expansion of the structure 55 within the cancellous bone region inside a bone can elevate or push the fractured cortical wall back to or near its anatomic position occupied before fracture occurred. Generally speaking, inadequate compaction of cancellous bone results in less lifting of contiguous cortical bone.
  • For practical reasons, it is desired that the expanded shape of the structure 55 inside bone, when in contact with cancellous bone, substantially conforms to the shape of the structure 56 outside bone, when in an open air environment. This allows the physician to select in an open air environment a structure having an expanded shape desired to meet the targeted therapeutic result, with the confidence that the expanded shape inside bone will be similar in important respects.
  • An optimal degree of shaping can be achieved by material selection and by special manufacturing techniques, e.g., thermoforming or blow molding, as will be described in greater detail later.
  • 3. Toughness Property
  • A third desired property for the material of the structure 56 is the ability to resist surface abrasion, tearing, and puncture when in contact with cancellous bone.
  • This property can be characterized in various ways. For example, a Taber Abrasion Resistance Value of less than about 90 mg loss indicates resistance to puncture when contacting cancellous bone. A Rotating Drum Abrasion Resistance Value of less than 70 mm3 also indicates resistance to puncture when contacting cancellous bone. This property can further be characterized, e.g., by an Elmendorf tear strength of greater than about 280 lbf/in, which indicates resistance to failure caused by cancellous bone abrasion. This property can also be characterized, e.g., by a Shore Hardness value of less than about 100 A. This value indicates a degree of elasticity, flexibility, and ductility.
  • Materials with a Taber Abrasion Resistance Value greater than about 90 mg loss, or a Rotating Drum Abrasion Resistance Value greater than about 70 mm3, or an Elmendorf tear strength value of less than about 280 lbf/in, or a Shore Hardness value greater than about 100 A are not well suited for expansion in cancellous bone, because failure may occur prior to expansion to the desired diameter.
  • B. Enhanced Expansion and Shape Properties
  • The expansion and shape properties just described can be enhanced and further optimized for compacting cancellous bone by selecting an elastomer material, which also possess the capability of being preformed, i.e., to acquire a desired shape by exposure, e.g., to heat and pressure, e.g., through the use of conventional thermoforming or blow molding techniques. Candidate materials that meet this criteria include polyurethane, silicone, thermoplastic rubber, nylon, and thermoplastic elastomer materials. In a most preferred embodiment, polyurethane material is used.
  • 1. Single Preformed Expandable Structures
  • In the embodiment shown in FIG. 4A, the structure 55 comprises an elongated tube 16 made from a polyurethane material. The tube 15 possesses end regions 18 and 20, each having a first diameter (designated D1 in FIG. 4A). The tube 16 further includes an intermediate preformed region 22. The diameter of the preformed intermediate region 22 has been enlarged by exposure to heat and pressure to a normally expanded shape having an enlarged diameter (designated D3 in FIG. 4A) greater than the first diameter D1. The normally expanded shape D3 exists in an open air environment, prior to placement inside an interior body region.
  • As FIG. 5 shows, the tube 16 is initially formed from polyurethane (or another preferred) material, for example, by standard polymer extrusion and molding processes. As FIGS. 5 and 7 show, the shaped region 22 is created by exposing the region 22 to heat within a fixture or mold 10, while positive interior pressure is applied to the tube 15 within the region 22. The fixture 10 includes a cavity 24, in which the region 22 rests while heat and pressure are applied. The cavity 24 has a geometry that the region 22 is intended to assume when inflated with interior pressure in the fixture 10. In the illustrated embodiment, a generally spherical shape is envisioned.
  • The heat can be applied by coupling the cavity 24 to a source 120 of heat energy of the fixture 10 itself (as FIG. 7 shows), or conveying a hot air stream or the equivalent into the cavity 24. The temperature selected is that at which the tube material will soften and form.
  • The range of temperatures in which softening occurs will depend upon the particular composition of the polymeric material used. For example, for polyurethane, the softening temperature lays in the range of about 50° C. to about 190° C. An operating range of softening temperatures for a given plastic material can be empirically determined.
  • As FIG. 7 shows, while in a heat-softened state and confined within the cavity 24, one end region 18 is coupled to a source 34 of pressurized fluid. The other end region 20 not coupled to the source 34 is closed with a cap 122 or otherwise blocked to retain pressurized fluid in the tube 16. Preferably, the pressurized fluid is air or an inert gas, designated A in FIG. 7.
  • The magnitude of pressure will vary depending upon the wall thickness and other physical characteristics of the elastomer material used. The pressure must be less than the burst strength of the tube material. Typically, air pressure in the range of 5 to 1000 D8i can be used.
  • The introduction of pressurized air A into the tube 16 causes the heat-softened region 22 to expand or billow outwardly in the cavity 24, as FIG. 7 shows. The cavity 24 limits the extent to which the heat-softened region 22 can expand. The region 22 will, upon expansion, conform to the geometry of the cavity 24. The extension of the heat-softened material in the cavity 24 uniformly relieves material stress in the region 22, as the region 22 acquires a new expanded shape, having the enlarged diameter D3 shown in FIG. 4A.
  • The application of heat is terminated, and the region 22 is allowed to cool, while pressurized fluid is applied to maintain the enlarged diameter D3. The region 22 can be cooled by an ambient external air flow, or by a pressurized stream of cooling air. Alternatively, the cavity 24 can include interior passages through which a cooling fluid can be circulated. The speed at which cooling occurs affects the time of the overall process.
  • After cooling, the application of pressurized fluid is terminated. The now preformed structure 56 is removed from the cavity 24.
  • The normally expanded shape characteristics of the structure 55 can be achieved by other techniques. For example, the structure 56 can be formed by dipping, lost wax casting, or injection molding.
  • Upon removal from the fixture 10, the structure 55 is secured to the distal end 54 of the catheter tube 50. The structure of the catheter tube 50 can vary and is not critical to the invention per se. The materials for the catheter tube 50 are selected to facilitate advancement of the structure 55 into an interior body region. The catheter tube 50 can be constructed, for example, using standard flexible, medical grade plastic materials, like vinyl, nylon, polyethylenes, ionomer, polyurethane, and polyethylene tetraphthalate (PET). The catheter tube 50 can also include more rigid materials to impart greater stiffness and thereby aid in its manipulation. More rigid materials that can be used for this purpose include Kevlar™ material, PEBAX™ material, stainless steel, nickel-titanium alloys (Nitinol™ material), and other metal alloys.
  • In the illustrated embodiment (as best shown in FIG. 4A), the catheter tube 50 includes an interior bore 50, in which an auxiliary tube 58 is secured. It should be appreciated that the catheter tube 50 can have more than a single interior lumen, and can, e.g., have an array of multiple lumens. In the illustrated embodiment, The auxiliary tube 58 extends through the interior bore 60 and beyond the distal end 54 of the catheter tube 50. One end region 18 of the tube 16 is secured to the distal end 54 of the catheter tube 50, while the other end region 20 is secured to the free extended end 62 of the auxiliary tube 58. The end regions 18 and 20 can be secured, e.g., using adhesive or thermal bonding processes.
  • By drawing a vacuum (i.e., negative pressure) inside the structure 56, resident air volume is removed, and the diameter of the region 22 is diminished from its normally expanded shape D3 to a substantially collaD8ed, and not inflated diameter D2. The collaD8ed diameter D2 is, due to forming during the heat and pressure shaping process, still different than the extruded or molded diameter D1. When substantially collaD8ed or not inflated, the structure 56 exhibits a low profile, ideal for insertion into the targeted cancellous bone region. The low profile can be further reduced to aid insertion, if desired, by enclosing the structure 56 within a constricted introducing sleeve, or by coating the structure 56 with a lubricious material, such as silicone, or both.
  • As FIGS. 3 and 4 show, the interior bore 60 of the catheter tube 50 can be coupled (via the fitting 122) to a source 68 of fluid, for example, sterile saline, or a radiopaque contrast medium, which permits x-ray visualization of the structure 56. The interior bore 60 conveys the fluid into the region 22. The increase of volume within the region up to a given threshold amount (designated V(D3) in FIG. 10) will return the intermediate region 22 from the collaD8ed diameter D2 to the normal (i.e., enlarged, but not distended) geometry, having the shape and diameter D3.
  • When in its normally enlarged shape D3, the material of the structure 55 in the region 22 is not significantly stretched or stressed, because it has been previously expanded in a stress-relieved condition into this geometry in the cavity 24.
  • The magnitude of the radius of expansion (and thus diameter D3) depends upon the relative increase in diameter in the region 22 brought about by exposure to heat and interior pressure within the cavity 24. The relative increase between the extruded or molded tube diameter D1 and diameter D3 should be at least 5% to provide tube length and geometry of the segment when it expands beyond diameter D3.
  • As FIG. 4B shows, due to expansion of heat-softened material under pressure in the cavity 24, the wall thickness of the structure 56 is not uniform. The region 22 has a minimum wall thickness T3 when in its normally enlarged diameter D3, which is less than the normal extruded or molded wall thickness (T1) of the tube 86.
  • Continued volume flow of pressurized fluid into the structure 56 at the threshold pressure P(t) continues to increase the interior volume of the structure 56. As its volume increases, the shaped region 22 of the structure 56 continues to enlarge beyond the normal diameter D3 toward a distended shape and geometry, designated D4 in FIG. 4. The threshold pressure P(t) stays generally constant as volume increases between D3 and D4. As long as volume is controlled (i.e., so as not to substantially exceed D4), there is no need for an external pressure regulator. Volume expansion between D3 and D4 at a substantially constant pressure occurs because of the material properties of the structure 56, and not because of some external pressure control mechanism.
  • Enlargement of the structure in the region between D3 and D4 stretches the material in the region 22 beyond its stress-relieved condition. Consequently, the wall thickness T4 at the distended geometry D4 is less than the minimum wall thickness T3 of the normally enlarged diameter D3. However, the distended geometry generally maintains the preformed shape dictated by the cavity 24 (which, in the illustrated embodiment, is spherical).
  • In the expansion region between D3 and D4, the addition of fluid volume at substantially constant P(t) stretches the material, causing the radius of the structure 55 to increase and the wall thickness to decrease. Material stress will increase.
  • While expanding in the region between D3 and D4, the structure 56, when inside bone, assumes an increasingly larger surface and volume, thereby compacting surrounding cancellous bone. Inflation in cancellous bone may occur at the same threshold pressure P(t) as outside bone. However, an increase in the threshold inflation pressure P(t) inside bone may be required, due to the density of the cancellous bone and resistance of the cancellous bone to compaction. In this instance, the configuration of the Pressure vs. Volume curve for a given material and structure 56 remains essentially the same as shown in FIG. 10, except that the generally horizontal portion of the curve between D3 and D4 is shifted upward on the Y-axis, as shown in phantom lines in FIG. 10. As a general statement, the threshold pressure inside bone is determined by the material property of the structure 56 and any added resistance due to the presence of cancellous bone.
  • The distance between D3 and D4, along the x-axis of FIG. 10, defines the degree to which the wall can elongate at a substantially constant pressure condition and with increasing material stress to compact cancellous bone, without failure. As volume increases at the substantially constant threshold pressure P(t), wall failure becomes more likely as the diameter of the structure enlarges significantly further beyond the distended diameter D4. There comes a point when the structure 56 can no longer increase its volume as the material elasticity approaches ultimate elongation, or as material stress approaches ultimate tensile strength. When either of these ultimate values are reached, wall failure is likely.
  • The distance between D3 and D4 in FIG. 10 during expansion inside bone is a simultaneous expression of the three physical and mechanical properties—expansion, shape, and toughness—described above. For example, a material possessing the requisite elasticity and shape, but lacking requisite toughness, but may fail short of the shape D4 due to abrasion and tearing caused by cancellous bone.
  • 2. Complex Preformed Expandable Structures
  • Sometimes it can be difficult to achieve a desired uniformity and area of compaction within a given cancellous bone region using a expandable body 56 having a single expandable region 22, such as shown in FIG. 4. FIG. 12 shows a complex preformed structure 80 includes segmented expandable regions 82 and 84 spaced along its length. The structure 80 provides a longer profile along which volume can be increased.
  • The complex expandable structure 80 is created by extruding or molding a tube 86 of polyurethane or elastomer material, like the tube 16 shown in FIG. 5. In the preferred embodiment, the tube 86 is made of a polyurethane material. The tube has a normal extruded wall thickness (T5) and a normal extruded outside diameter (D5) (as shown in FIG. 12).
  • The segmented shaped regions 82 and 84 are created by exposing an intermediate region 88 of the tube 86 to heat and positive interior pressure inside a fixture or mold 90, as shown in FIG. 13. In the illustrated embodiment, the fixture 90 possesses two cavity regions 92 and 94 with an intermediate channel 96. The intermediate region 88 is located in the cavities 92 and 94 and channel 96.
  • The cavity regions 92 and 94 and the channel 95 are exposed to a source of heat 120, to soften the material of the region 88. When heat-softened (in the manner previously described), the interior of the tube 86 is subjected to positive pressure from a source 34 (as also previously described). The material in the region 88 expands or extends within the cavities 92 and 94 and the channel 96 Once cooled and removed from the fixture 90, the structure 80 can be attached to the distal end of a catheter tube 50 in the same fashion as the structure 56 shown in FIGS. 3 and 4.
  • The structure 80 possesses, in an open air environment, a normal expanded shape, having diameter D7 (shown in phantom lines in FIG. 12). The normal shape and diameter D7 for the regions 82 and 84 generally correspond with the shape and dimension of the cavities 92 and 94, respectively.
  • When an interior vacuum is drawn, removing air from the structure 80, the structure 80 assumes a substantially collaD8ed, and not inflated geometry, shown in phantom lines D6 in FIG. 12. Due to the application of heat and pressure upon the region 88, diameter D6 for each region 82 and 84 is larger than the normal extruded or molded outside diameter D5 of the original extruded tube 86.
  • The regions 82 and 84 are separated by a tubular neck 98, which segments the structure 80 into two expandable regions 82 and 84. When substantially collaD8ed under vacuum or not inflated, the structure 80 exhibits a low profile, ideal for insertion into the targeted cancellous bone region.
  • The introduction of fluid volume back into the tube 86 will cause each region 82 and 84 to return from the collapsed diameter D5 back to the normal, enlarged, but not distended geometry, having the shape and diameter shown in phantom lines D7 in FIG. 12.
  • In the illustrated embodiment, the first and second shaped regions 82 and 84 have generally the same radius of expansion and thus the same non-distended shape and diameter D7. Alternatively, each region 82 and 84 can have a different radius of expansion, and thus a different non-distended shape and diameter. Regardless, when in the normal, non-distended diameter D7, the material of the structure 80 in the region 88 is not significantly stretched or stressed, because the regions 82 and 84 have been previously expanded in a stress-relieved condition into this geometry in the cavities 92 and 94.
  • As before explained in conjunction with the structure 56, the regions 82 and 84 can be shaped by heat and interior pressure within different cavities to assume different geometries, e.g., cylindrical or elliptical geometry, or a non-spherical, non-cylindrical, or non-elliptical geometry, with either uniform or complex curvature, and in either symmetric or asymmetric forms. Of course, more than two segmented regions 82 and 84 can be formed along the length of the tube 86.
  • Each shaped region 82 and 84 possesses a minimum wall thickness (designed T7 in FIG. 12) when in the normally enlarged but not distended geometry D7. Due to expansion of heat-softened material under pressure in the cavities 92 and 94, the wall thickness is not uniform, i.e., T7 is less than the normal extruded or molded wall thickness T5 of the tube 85. The minimum wall thicknesses T7 for the regions 82 and 84 can be the same or different.
  • When in the enlarged, but not distended geometry, the neck region 98 has an outside diameter (designated D9 in FIG. 14), which is equal to or greater than the normal extruded or molded diameter D5 of the tube 86. The size of the channel 96 in the fixture 90 determines the magnitude of the diameter D9. Due to expansion of heat-softened material in the adjacent regions 82 and 84 under pressure in the cavities 92 and 94, the neck region 98 (which expands under pressure in the channel 96) has a wall thickness (designated T9 in FIG. 12) which is less than or equal to the normal extruded or molded wall thickness TE of the tube 86, but still greater than the minimum wall thickness T7 of either fully shaped region 82 or 84.
  • The formed complex structure 80 thus possesses regions of non-uniform minimum wall thickness along its length; that is, T5≧T9>T7. The formed complex structure 80 also provides multiple expandable regions 82 and 84 of the same or different enlarged outside diameters (D7), segmented by a neck region 98, in which D6>D5; D7>D6; and D7>D9.
  • By continuing to apply fluid volume at a constant pressure at a threshold amount P(t), and thereby increasing the volume within the structure 80, the shaped regions 82 and 84 of the structure 80 will continue to enlarge beyond diameter D7 to a distended shape and geometry, designated D8 in FIG. 12. The wall thickness T7 further decreases and approaches T8. As the regions 82 and 84 approach diameter D8, the diameter D9 of the neck region 98 will likewise increase toward diameter D10, as FIG. 12 shows, providing more-uniform, elongated surface contact with cancellous bone.
  • Enlargement of the structure 80 beyond diameter D7 stretches the material in the regions 82, 84, and 98 beyond their stress-relieved condition, although the distended geometry of the regions 82 and 84 will, in important respects, maintain the preformed shape dictated by the cavities 92 and 94. As before explained in conjunction with the structure 55, the material in the regions 82 and 84 has already been stress-relieved in the desired shape at the normal diameter D7. As previously explained, enlargement toward the distended diameter D8 occurs at substantially constant pressure (as FIG. 10 exemplifies), and at increasing material stress.
  • The degree of stretching at a substantially constant incremental pressure condition can be tailored to achieve a desired, fully distended diameter D8. The final, fully distended diameter D8 can be selected to match the dimensions of the targeted cancellous bone region. The controlled stretching of the segmented regions 82 and 84 in tandem can provide an equal volume compression of cancellous bone with a major diameter that is less than a single non-segmented region (i.e., one without the neck region 98). Stated another way, segmented regions 82 and 84, when expanded to a given inflation volume, have a diameter less than a sphere expanded to an equal inflation volume.
  • While expanding in the region between D7 and D8, the structure 80, like the structure 56, when inside bone, assumes an increasingly larger surface and volume, thereby compacting surrounding cancellous bone. Inflation in cancellous bone may occur at the same threshold pressure P(t) as outside bone. However, an increase in the threshold inflation pressure P(t) inside bone may be required, due to the density of the cancellous bone and resistance of the cancellous bone to compaction.
  • 3. Composite Expandable Structures
  • In the previous embodiments, the material of the structure 56 or 80 is selected to integrate all desired physical and mechanical requirements of expansion, shape, and toughness. FIG. 16 exemplifies a composite expandable structure 130, in which the desired physical and mechanical requirements are segregated by the use of different materials.
  • As shown in FIG. 15, the composite structure 130 includes an inner expandable body 132 made of a first material that meets one or more of the desired requirements of expansion and shape. The composite structure 130 includes an outer expandable body or shell 134, which is made of a second material that meets the desired requirement of toughness. The shell 134 encaD8ulates and protects the inner expandable body 132 from surface abrasion, tearing, or puncture due to contact with cancellous bone.
  • The shell 134 can comprise a material applied to the surface of the inner body by various dipping, painting, or coating techniques. Alternatively, the shell 134 can comprise a bag or sock, into which the inner body 132 is placed prior to deployment. The material for the shell 134 can comprise, e.g., rubber, silicone, ethylene vinyl acetate, polyurethane, polyethylene, or multi-filament woven material or fabric or other polymer material.
  • The composite structure 130 makes it possible to isolate the expansion and shape requirements from the toughness requirement A material completely or partially failing to meet the toughness requirement can nevertheless be used for the inner body 132 to optimize the expansion and shape requirements of the structure 130. The inner body 132 imparts its optimized expansion and shape characteristics to cancellous bone, while the shell 134 imparts its Optimized toughness characteristic to the overall composite structure 130.
  • II. Deployment of Preformed Expandable Structures in Bone
  • The structure 56 or 80 or 130 can be inserted into bone in accordance with the teachings of U.S. Pat. Nos. 4,969,888 and 5,108,404, which are incorporated herein by reference. As FIG. 8 shows, access can be accomplished, for example, by drilling an access portal 64 through a side of the vertebral body 25. This is called a postero-lateral approach. Alternatively, the access portal can pass through either pedicle 42, which called a transpedicular approach.
  • A guide sheath or cannula 66 placed into communication with the access portal 64. The catheter tube 50 is advanced through the cannula 65 to deploy the structure (FIG. 8 shows structure 55) into contact with cancellous bone 32. The structure 56 is in its normally collapsed and not inflated condition (shown as phantom line diameter D2 in FIG. 8) during deployment. Access in this fashion can be accomplished using a closed, minimally invasive procedure or with an open procedure.
  • The materials for the catheter tube 50 are selected to facilitate advancement of the expandable structure 56 into cancellous bone 32. The catheter tube 50 can be constructed, for example, using standard flexible, medical grade plastic materials, like vinyl, nylon, polyethylenes, ionomer, polyurethane, and polyethylene tetraphthalate (PET). The catheter tube 50 can also include more rigid materials to impart greater stiffness and thereby aid in its manipulation. More rigid materials that can be used for this purpose include stainless steel, nickel-titanium alloys (Nitinol™ material), and other metal alloys.
  • As FIG. 8 shows, expansion of the structure 56 to its enlarged but not distended geometry (phantom line diameter D3 in FIG. 8), and ultimately to its maximum distended geometry (diameter D4 in FIG. 8) sequentially compresses cancellous bone 32 in the vertebral body 26. The compression forms an interior cavity 70 in the cancellous bone 32. As FIG. 9 shows, subsequent collaD8e and removal of the structure 56 leaves the cavity 70 in a condition to receive a filling material, e.g., bone cement. The bone cement, when hardened, provides improved interior structural support for cortical bone 32.
  • The compaction of cancellous bone 32 shown in FIG. 8 also exerts interior force upon the surrounding cortical bone 28. The interior force can elevate or push broken and compressed bone back to or near its original prefracture, or other desired, condition.
  • In the case of a vertebral body 26, deterioration of cancellous bone 32 can cause the top and bottom plates (designated TP and BP in FIG. 2) to compress or move closed together, reducing the normal physiological height between the plates TP and BP. In this circumstance, the interior force exerted by the structure 56 as it compacts cancellous bone 32 moves one or both of the top and bottom plates TP and BP farther apart, to thereby restore a spacing between them, which is at or close to the normal physiological distance.
  • As shown in FIG. 11, in an alternative embodiment, a stiffening member or stylet 74 can be inserted through a lumen 72 of the auxiliary tube 58, which is enclosed within the structure 56. The stylet 74 can be made, e.g., from stainless steel or molded plastic material. The presence of the stylet 74 serves to keep the structure 55 in the desired distally straightened condition during passage through the guide sheath 66 into the targeted bone region, as FIG. 8 shows.
  • As further shown in FIG. 11, the stylet 74 can have a preformed memory, to normally bend its distal region. The memory is overcome to straighten the stylet 14 when confined within the guide sheath 56. However, as the structure 56 and preformed stylet 74 advance free of the guide sheath 66 and pass into the targeted region, the preformed memory bends the stylet 74. The bending stylet 74 bends the auxiliary tube 58 and thereby shifts the main axis 78 of the surrounding expandable structure 56 relative to the axis 78 of the access path (i.e., the guide sheath 66). The prebent stylet 74, positioned within the interior of the structure 56, aids in altering the orientation of the structure 56 within targeted region. It is thereby possible to orient the structure 56 in a more generally aligned relationship with the natural axes of the vertebral body 25. A cavity 70, more centrally located within the bone, e.g., a vertebral body 26, can be established, which provides more uniform support across the mid region of the vertebral body 26 when filled with bone cement. The capability of the vertebral body 26 to withstand loads is thereby enhanced. The symmetric compaction of cancellous bone 32 in the interior volume also exerts more equal and uniform interior forces upon cortical bone 32, to elevate or push broken and compressed bone.
  • There are times when a lesser amount of cancellous bone compaction is indicated. For example, when the bone disease being treated is localized, such as in avascular necrosis, or where local loss of blood supply is killing bone in a limited area, an expandable structure 56 or 80 or 130 can compact a smaller volume of total bone. This is because the diseased area requiring treatment is smaller.
  • Another exception lies in the use of an expandable structure 56 or 80 or 130 to improve insertion of solid materials in defined shapes, like hydroxyapatite and components in total joint replacement. In these cases, the structure shape and size is defined by the shape and size of the material being inserted.
  • Yet another exception lies in the use of expandable structures in bones to create cavities to aid in the delivery of therapeutic substances, as disclosed in copending U.S. patent application Ser. No. 08/485,394, previously mentioned. In this case, the cancellous bone may or may not be diseased or adversely affected. Healthy cancellous bone can be sacrificed by significant compaction to improve the delivery of a drug or growth factor which has an important therapeutic purpose. In this application, the size of the expandable structure 55 or 80 or 130 is chosen by the desired amount of therapeutic substance sought to be delivered. In this case, the bone with the drug inside may need to be supported by standard methods while the drug works and the bone heals.
  • III. Single Use
  • Distention of any one of the expandable structures 56 or 80 or 130 described herein during first use in a targeted body region generates stress on the material or materials which make up the structure. The material stress created by operational loads during first use in a targeted body region can significantly alter the preformed morphology of the structure, making future performance of the structure unpredictable.
  • For example, expansion within bone during a single use creates contact with surrounding cortical and cancellous bone. Regardless of the superior mechanical properties of material, this contact can in time damage the structure, creating localized regions of weakness, which may escape detection. Localized areas of lower density cancellous bone may result in creating areas of differential expansion and stress on the structure. The existence of localized regions of weakness or differential stress can unpredictably cause overall structural failure during a subsequent use.
  • In addition, exposure to blood and tissue during a single use can entrap biological components on or within the structure or the associated catheter tube.
  • Despite cleaning and subsequent sterilization, the presence of entrapped biological components can lead to unacceptable pyrogenic reactions.
  • As a result, following first use, the structure cannot be consistently relied upon to reach its desired configuration during subsequent use and may not otherwise meet established performance and sterilization specifications. The effects of material stress and damage caused during a single use, coupled with the possibility of pyrogen reactions even after resterilization, reasonably justify imposing a single use restriction upon devices which carry these expandable structures for deployment in bone.
  • To protect patients from the potential adverse consequences occasioned by multiple use, which include disease transmission, or material stress and instability, or decreased or unpredictable performance, the invention also provides a kit 100 (see FIGS. 14 and 15) for storing a single use tool 48 (also shown in FIG. 3) prior to use. As shown in FIG. 14, the tool 48 carries an expandable structure. FIG. 14 shows for the purpose of illustration the structure 56, as described herein. It should be appreciated that the tool 48 could carry an expandable structure 80 or 130, as also previously described.
  • In the illustrated embodiment (see FIGS. 14 and 15), the kit 100 includes an interior tray 108. The tray 108 holds the tool 48 in a lay-flat, straightened condition during sterilization and storage prior to its first use. The tray 108 can be formed from die cut cardboard or thermoformed plastic material. The tray 108 includes one or more spaced apart tabs 110, which hold the catheter tube 50 and expandable structure 55 in the desired lay-flat, straightened condition.
  • The kit 100 includes an inner wrap 112, which is peripherally sealed by heat or the like, to enclose the tray 108 from contact with the outside environment. One end of the inner wrap 112 includes a conventional peal-away seal 114, to provide quick access to the tray 108 upon instance of use, which preferably occurs in a sterile environment, such as within an operating room.
  • The kit 100 also includes an outer wrap 116, which is also peripherally sealed by heat or the like, to enclosed the inner wrap 112. One end of the outer wrap 116 includes a conventional peal-away seal 118, to provide access to the inner wrap 112, which can be removed from the outer wrap 116 in anticipation of imminent use of the probe 102, without compromising sterility of the probe 102 itself.
  • Both inner and outer wraps 112 and 116 (see FIG. 15) each includes a peripherally sealed top sheet 120 and bottom sheet 122. In the illustrated embodiment, the top sheet 120 is made of transparent plastic film, like polyethylene or MYLAR™ material, to allow visual identification of the contents of the kit 100. The bottom sheet 122 is made from a material that is permeable to ETO sterilization gas, e.g., TYVEK™ plastic material (available from Dupont).
  • The sterile kit 100 also carries a label or insert 106, which includes the statement “For Single Patient Use Only” (or comparable language) to affirmatively caution against reuse of the contents of the kit 100. The label 106 also preferably affirmatively instructs against resterilization of the tool 48. The label 105 also preferably instructs the physician or user to dispose of the tool 48 and the entire contents of the kit 100 upon use in accordance with applicable biological waste procedures. The presence of the probe 102 packaged in the kit 100 verifies to the physician or user that tool 48 is sterile and has not been subjected to prior use. The physician or user is thereby assured that the expandable structure 55 meets established performance and sterility specifications, and will have the desired configuration when expanded for use.
  • The label 106 preferably also instructs the physician as to the use of the expandable structure 56 (or 80 or 130) for compacting cancellous bone in the manners previously described. For example, the label 105 instructs the physician to expand the structure inside bone to compact cancellous bone and form a cavity. The label 106 can also instruct the physician to fill the cavity with a material, e.g., bone cement, allograft material, synthetic bone substitute, a medication, or a flowable material that sets to a hardened condition.
  • The features of the invention are set forth in the following claims.

Claims (24)

1. A system comprising
a first tool establishing a percutaneous access path to a bone structure having cortical bone enclosing a cancellous bone volume,
a second tool comprising an expandable structure sized and configured to be inserted into the bone structure through the percutaneous access path, the expandable structure comprising a wall made from a flexible material and including an expandable region preformed with a normally expanded shape outside bone, the expandable region being expandable beyond its normally expanded shape to reach an inflation volume sized and configured for forming a cavity in cancellous bone, the expandable region having a proximal expanded section, a distal expanded section, and an intermediate expanded section located between the proximal and distal expanded sections, the intermediate expanded section having, when the wall is in the normally expanded shape and at the inflation volume, an average wall thickness greater than average wall thicknesses of either the first and second sections, and
a third tool to convey a filler material into the cavity.
2. A system according to claim 1
wherein expansion of the expandable structure compacts cancellous bone.
3. A system according to claim 1
wherein the filler material comprises bone cement.
4. A system according to claim 1
wherein the filler material comprises synthetic bone substitute.
5. A system according to claim 1
wherein the filler material comprises a flowable material that sets to a hardened condition.
6. A system for treating bone comprising
a first tool establishing a percutaneous access path to a bone structure having cortical bone enclosing a cancellous bone volume,
a second tool comprising an expandable structure sized and configured to be inserted into the bone structure through the percutaneous access path, the expandable structure comprising a wall made from a flexible material and including an expandable region preformed with a normally expanded shape outside bone, the expandable region being expandable beyond its normally expanded shape to reach an inflation volume sized and configured to move fractured cortical bone, the expandable region having a proximal expanded section, a distal expanded section, and an intermediate expanded section located between the proximal and distal expanded sections, the intermediate expanded section having, when the wall is in the normally expanded shape and at the inflation volume, an average wall thickness greater than average wall thicknesses of either the first and second sections, and
a third tool to convey a filler material into the cancellous bone volume.
7. A system according to claim 6
wherein expansion of the expandable structure compacts cancellous bone.
8. A system according to claim 6
wherein expansion of the expandable structure forms a cavity in cancellous bone.
9. A system according to claim 6
wherein the filler material comprises bone cement.
10. A system according to claim 6
wherein the filler material comprises synthetic bone substitute.
11. A system according to claim 6
wherein the filler material comprises a flowable material that sets to a hardened condition.
12. A method for treating bone comprising
establishing a percutaneous access path to a bone structure having cortical bone enclosing a cancellous bone volume,
deploying an expandable structure into the cancellous bone volume through the percutaneous access path, the expandable structure comprising a wall made from a flexible material and including an expandable region preformed with a normally expanded shape outside bone, the expandable region being expandable beyond its normally expanded shape to reach an inflation volume sized and configured to form a cavity in cancellous bone, the expandable region having a proximal expanded section, a distal expanded section, and an intermediate expanded section located between the proximal and distal expanded sections, the intermediate expanded section having, when the wall is in the normally expanded shape and at the inflation volume, an average wall thickness greater than average wall thicknesses of either the first and second sections,
expanding the structure to the inflation volume to form a cavity in the cancellous bone volume, and
conveying a filler material into the cavity.
13. A method according to claim 12
wherein the filler material comprises bone cement.
14. A method according to claim 12
wherein the filler material comprises synthetic bone substitute.
15. A method according to claim 12
wherein the filler material comprises a flowable material that sets to a hardened condition.
16. A method for treating bone comprising
establishing a percutaneous access path to a bone structure having cortical bone enclosing a cancellous bone volume,
deploying an expandable structure into the cancellous bone volume through the percutaneous access path, the expandable structure comprising a wall made from a flexible material and including an expandable region preformed with a normally expanded shape outside bone, the expandable region being expandable beyond its normally expanded shape to reach an inflation volume sized and configured to move fractured cortical bone, the expandable region having a proximal expanded section, a distal expanded section, and an intermediate expanded section located between the proximal and distal expanded sections, the intermediate expanded section having, when the wall is in the normally expanded shape and at the inflation volume, an average wall thickness greater than average wall thicknesses of either the first and second sections,
expanding the structure to the inflation volume to move fractured cortical bone, and
conveying a filler material into the cancellous bone volume.
17. A method according to claim 16
wherein expansion of the structure compacts cancellous bone.
18. A method according to claim 16
wherein expansion of the structure forms a cavity in cancellous bone.
19. A method according to claim 16
wherein the filler material comprises bone cement.
20. A method according to claim 16
wherein the filler material comprises synthetic bone substitute.
21. A method according to claim 16
wherein the filler material comprises a flowable material that sets to a hardened condition.
22. A method comprising
selecting a vertebral body for treatment, the vertebral body having a cortical wall enclosing a cancellous bone volume,
providing an expandable device including an expanded configuration and an unexpanded configuration, the expandable device comprising a wall made from a flexible material and including an expandable region preformed with a normally expanded shape outside bone, the expandable region being expandable beyond its normally expanded shape to reach an inflation volume sized and configured to form a cavity in cancellous bone, the expandable region having a proximal expanded section, a distal expanded section, and, an intermediate expanded section located between the proximal and distal expanded sections, the intermediate expanded section having, when the wall is in the normally expanded shape and at the inflation volume, an average wall thickness greater than average wall thicknesses of either the first and second sections to control the expansion so that the expandable device expands more in an inferior-to-superior direction than in a lateral direction,
introducing the expandable device into the vertebral body through a percutaneous access path while in the unexpanded condition, and
expanding the expandable device while disposed within the cancellous bone volume from the unexpanded configuration toward the expanded configuration to form the cavity.
23. A method according to claim 22
and further including conveying a filler material into the cavity.
24. A method according to claim 22
wherein expansion of the expandable device moves fractured cortical bone.
US11/978,412 1998-06-01 2007-10-29 Expandable preformed structures for deployment in interior body regions Abandoned US20080065139A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/978,412 US20080065139A1 (en) 1998-06-01 2007-10-29 Expandable preformed structures for deployment in interior body regions

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US8845998A 1998-06-01 1998-06-01
US09/837,350 US6979341B2 (en) 1994-01-26 2001-04-18 Expandable preformed structures for deployment in interior body regions
US11/299,172 US20060095064A1 (en) 1998-06-01 2005-12-09 Expandable preformed structures for deployment in interior body regions
US11/978,412 US20080065139A1 (en) 1998-06-01 2007-10-29 Expandable preformed structures for deployment in interior body regions

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11/299,172 Division US20060095064A1 (en) 1998-06-01 2005-12-09 Expandable preformed structures for deployment in interior body regions

Publications (1)

Publication Number Publication Date
US20080065139A1 true US20080065139A1 (en) 2008-03-13

Family

ID=22211509

Family Applications (5)

Application Number Title Priority Date Filing Date
US09/420,529 Expired - Lifetime US6607544B1 (en) 1994-01-26 1999-10-19 Expandable preformed structures for deployment in interior body regions
US09/837,350 Expired - Fee Related US6979341B2 (en) 1994-01-26 2001-04-18 Expandable preformed structures for deployment in interior body regions
US10/617,895 Abandoned US20040010263A1 (en) 1998-06-01 2003-07-11 Expandable preformed structures for deployment in interior body regions
US11/299,172 Abandoned US20060095064A1 (en) 1998-06-01 2005-12-09 Expandable preformed structures for deployment in interior body regions
US11/978,412 Abandoned US20080065139A1 (en) 1998-06-01 2007-10-29 Expandable preformed structures for deployment in interior body regions

Family Applications Before (4)

Application Number Title Priority Date Filing Date
US09/420,529 Expired - Lifetime US6607544B1 (en) 1994-01-26 1999-10-19 Expandable preformed structures for deployment in interior body regions
US09/837,350 Expired - Fee Related US6979341B2 (en) 1994-01-26 2001-04-18 Expandable preformed structures for deployment in interior body regions
US10/617,895 Abandoned US20040010263A1 (en) 1998-06-01 2003-07-11 Expandable preformed structures for deployment in interior body regions
US11/299,172 Abandoned US20060095064A1 (en) 1998-06-01 2005-12-09 Expandable preformed structures for deployment in interior body regions

Country Status (12)

Country Link
US (5) US6607544B1 (en)
EP (1) EP1083836B1 (en)
JP (2) JP4393706B2 (en)
AT (1) ATE484247T1 (en)
AU (1) AU756969B2 (en)
CA (1) CA2333761C (en)
DE (1) DE69942858D1 (en)
ES (1) ES2354492T3 (en)
IL (1) IL140013A0 (en)
NO (1) NO20006089L (en)
NZ (1) NZ508401A (en)
WO (1) WO1999062416A1 (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090034952A1 (en) * 2006-04-07 2009-02-05 Lab Partners Associates, Inc. Wireless Camera Flash Synchronizer System and Method
US20110123185A1 (en) * 2007-05-29 2011-05-26 Lab Partners Associates, Inc. External Photographic Wireless TTL Communication Device and Method
US8326141B1 (en) 2009-02-12 2012-12-04 Lab Partners Associates, Inc. Systems and methods for changing power states of a remote device using one or more camera body controls and a preset delay
US8326136B1 (en) 2009-02-12 2012-12-04 Lab Partners Associates, Inc. Systems and methods for communicating with a device using one or more camera body controls
US8571406B2 (en) 2009-02-12 2013-10-29 Lab Partners Associates, Inc. Early photographic predictor signal synchronization system and method
US8614766B1 (en) 2009-02-12 2013-12-24 Lab Partners Associates, Inc. Systems and methods for controlling a power state of a remote device using camera body backlighting control signaling
US9220554B2 (en) 2010-02-18 2015-12-29 Globus Medical, Inc. Methods and apparatus for treating vertebral fractures
EP3322366A4 (en) * 2015-07-15 2019-03-20 Mayo Foundation for Medical Education and Research Bone expansion devices and methods
US10959761B2 (en) 2015-09-18 2021-03-30 Ortho-Space Ltd. Intramedullary fixated subacromial spacers
US11033398B2 (en) 2007-03-15 2021-06-15 Ortho-Space Ltd. Shoulder implant for simulating a bursa
US11045981B2 (en) 2017-01-30 2021-06-29 Ortho-Space Ltd. Processing machine and methods for processing dip-molded articles
US11229466B2 (en) 2018-01-12 2022-01-25 KyphEZE, Inc. Bone expansion systems and methods
US11826228B2 (en) 2011-10-18 2023-11-28 Stryker European Operations Limited Prosthetic devices

Families Citing this family (351)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716216B1 (en) 1998-08-14 2004-04-06 Kyphon Inc. Systems and methods for treating vertebral bodies
EP1464293B1 (en) * 1994-01-26 2007-05-02 Kyphon Inc. Improved inflatable device for use in surgical methods relating to fixation of bone
US20030229372A1 (en) * 1994-01-26 2003-12-11 Kyphon Inc. Inflatable device for use in surgical protocols relating to treatment of fractured or diseased bone
US6248110B1 (en) 1994-01-26 2001-06-19 Kyphon, Inc. Systems and methods for treating fractured or diseased bone using expandable bodies
US20060100635A1 (en) * 1994-01-26 2006-05-11 Kyphon, Inc. Inflatable device for use in surgical protocol relating to fixation of bone
US20030032963A1 (en) * 2001-10-24 2003-02-13 Kyphon Inc. Devices and methods using an expandable body with internal restraint for compressing cancellous bone
US6241734B1 (en) * 1998-08-14 2001-06-05 Kyphon, Inc. Systems and methods for placing materials into bone
WO2003059213A2 (en) * 1994-01-26 2003-07-24 Kyphon Inc. Inflatable device for use in surgical protocol relating to fixation of bone
US20030157074A1 (en) * 1994-11-16 2003-08-21 Mitrani Eduardo N. Vitro micro-organs, and uses related thereto
US20050131268A1 (en) * 1995-06-07 2005-06-16 Talmadge Karen D. System and method for delivering a therapeutic agent for bone disease
US20050131267A1 (en) * 1995-06-07 2005-06-16 Talmadge Karen D. System and method for delivering a therapeutic agent for bone disease
WO2006053312A1 (en) * 1995-06-07 2006-05-18 Kyphon Inc. System and method for delivering a therapeutic agent for bone disease
US20050131269A1 (en) * 1995-06-07 2005-06-16 Talmadge Karen D. System and method for delivering a therapeutic agent for bone disease
IL128261A0 (en) 1999-01-27 1999-11-30 Disc O Tech Medical Tech Ltd Expandable element
US5972015A (en) 1997-08-15 1999-10-26 Kyphon Inc. Expandable, asymetric structures for deployment in interior body regions
US6645213B2 (en) * 1997-08-13 2003-11-11 Kyphon Inc. Systems and methods for injecting flowable materials into bones
US7687057B2 (en) * 1998-01-09 2010-03-30 Yissum Research Development Company Of The Hebrew University Of Jerusalem In vitro micro-organs, and uses related thereto
ES2354492T3 (en) 1998-06-01 2011-03-15 Kyphon Sarl PREFORMED STRUCTURES EXPANDABLE FOR DEPLOYMENT IN INTERNAL BODY REGIONS.
US6719773B1 (en) 1998-06-01 2004-04-13 Kyphon Inc. Expandable structures for deployment in interior body regions
RU2296526C2 (en) * 1998-10-26 2007-04-10 Икспэндинг Ортопедикс Инк. Expandable orthopedic device
US7621950B1 (en) 1999-01-27 2009-11-24 Kyphon Sarl Expandable intervertebral spacer
WO2000053077A2 (en) * 1999-03-07 2000-09-14 Discure Ltd. Method and apparatus for computerized surgery
US6740093B2 (en) 2000-02-28 2004-05-25 Stephen Hochschuler Method and apparatus for treating a vertebral body
US6402750B1 (en) * 2000-04-04 2002-06-11 Spinlabs, Llc Devices and methods for the treatment of spinal disorders
US6805695B2 (en) 2000-04-04 2004-10-19 Spinalabs, Llc Devices and methods for annular repair of intervertebral discs
ATE318559T1 (en) * 2000-04-05 2006-03-15 Kyphon Inc DEVICES FOR TREATING BROKEN AND/OR DISEASE BONES
AU2001253183B2 (en) 2000-04-07 2006-07-27 Kyphon Sarl Insertion devices and method of use
US7815649B2 (en) 2000-04-07 2010-10-19 Kyphon SÀRL Insertion devices and method of use
CN100486536C (en) 2000-07-14 2009-05-13 科丰公司 Systems for inducting material into bone
ES2341641T3 (en) 2000-07-21 2010-06-24 The Spineology Group, Llc AN EXPANSIBLE POROUS MESH BAG DEVICE AND ITS USE FOR OSEA SURGERY.
US20080086133A1 (en) * 2003-05-16 2008-04-10 Spineology Expandable porous mesh bag device and methods of use for reduction, filling, fixation and supporting of bone
GB0019107D0 (en) * 2000-08-03 2000-09-27 Ranier Ltd Balloon-free uninary catheter
US7499742B2 (en) * 2001-09-26 2009-03-03 Cvrx, Inc. Electrode structures and methods for their use in cardiovascular reflex control
EP1328203B1 (en) 2000-10-25 2009-11-18 Kyphon SÀRL Systems for reducing fractured bone using a fracture reduction cannula
US6746451B2 (en) * 2001-06-01 2004-06-08 Lance M. Middleton Tissue cavitation device and method
US20030050644A1 (en) * 2001-09-11 2003-03-13 Boucher Ryan P. Systems and methods for accessing and treating diseased or fractured bone employing a guide wire
BR0214065A (en) * 2001-11-05 2004-12-07 Medgenics Inc Method and apparatus for producing a skin graft and graft produced in this manner
US20040127563A1 (en) * 2002-03-22 2004-07-01 Deslauriers Richard J. Methods of performing medical procedures which promote bone growth, compositions which promote bone growth, and methods of making such compositions
US6960215B2 (en) * 2002-05-08 2005-11-01 Boston Scientific Scimed, Inc. Tactical detachable anatomic containment device and therapeutic treatment system
US20040011532A1 (en) * 2002-07-16 2004-01-22 White Jack D. Combined rod guide and rod rotator device
AU2003265667A1 (en) * 2002-08-27 2004-03-19 Warsaw Orthopedic, Inc. Systems and methods for intravertebral reduction
US6932843B2 (en) 2002-09-25 2005-08-23 Medicinelodge, Inc. Apparatus and method for the in-situ formation of a structural prosthesis
US7488337B2 (en) * 2002-09-30 2009-02-10 Saab Mark A Apparatus and methods for bone, tissue and duct dilatation
US9782572B2 (en) 2002-09-30 2017-10-10 Nordson Corporation Apparatus and methods for treating bone structures, tissues and ducts using a narrow gauge cannula system
CA2735324A1 (en) * 2002-11-05 2004-05-21 Spineology, Inc. A semi-biological intervertebral disc replacement system
DE602004018903D1 (en) 2003-02-14 2009-02-26 Depuy Spine Inc IN-SITU MANUFACTURED INTERVERTEBRALE FUSION DEVICE
US20080033446A1 (en) * 2003-03-11 2008-02-07 Kwan-Ku Lin Flexible and breathable filler for medical application
DE60335037D1 (en) 2003-03-14 2010-12-30 Depuy Spine Inc HYDRAULIC DEVICE FOR BONE CEMENT INJECTION IN PERCUTANEOUS VERTEBROPLASTY
US7306610B2 (en) * 2003-03-21 2007-12-11 Cana Lab Corporation Method and device for forming a hardened cement in a bone cavity
US8066713B2 (en) 2003-03-31 2011-11-29 Depuy Spine, Inc. Remotely-activated vertebroplasty injection device
US20040220672A1 (en) * 2003-05-03 2004-11-04 Shadduck John H. Orthopedic implants, methods of use and methods of fabrication
TWI235055B (en) * 2003-05-21 2005-07-01 Guan-Gu Lin Filling device capable of removing animal tissues
TW587932B (en) * 2003-05-21 2004-05-21 Guan-Gu Lin Removable animal tissue filling device
US7569626B2 (en) 2003-06-05 2009-08-04 Dfine, Inc. Polymer composites for biomedical applications and methods of making
US20070032567A1 (en) * 2003-06-17 2007-02-08 Disc-O-Tech Medical Bone Cement And Methods Of Use Thereof
US8415407B2 (en) 2004-03-21 2013-04-09 Depuy Spine, Inc. Methods, materials, and apparatus for treating bone and other tissue
US7744620B2 (en) 2003-07-18 2010-06-29 Intervalve, Inc. Valvuloplasty catheter
WO2005009299A1 (en) * 2003-07-25 2005-02-03 Impliant Ltd. Elastomeric spinal disc nucleus replacement
CN2638760Y (en) * 2003-08-04 2004-09-08 邹德威 Dilator for forming cavity in pyramid
MXPA06002541A (en) 2003-09-03 2006-06-20 Kyphon Inc Devices for creating voids in interior body regions and related methods.
WO2005030034A2 (en) 2003-09-26 2005-04-07 Depuy Spine, Inc. Device for delivering viscous material
TW200511970A (en) * 2003-09-29 2005-04-01 Kwan-Ku Lin A spine wrapping and filling apparatus
US7513900B2 (en) * 2003-09-29 2009-04-07 Boston Scientific Scimed, Inc. Apparatus and methods for reducing compression bone fractures using high strength ribbed members
WO2005048856A1 (en) * 2003-11-10 2005-06-02 Umc Utrecht Holding B.V. Expandable implant for treating fractured and/or collapsed bone
US7524103B2 (en) * 2003-11-18 2009-04-28 Boston Scientific Scimed, Inc. Apparatus for mixing and dispensing a multi-component bone cement
US7488324B1 (en) 2003-12-08 2009-02-10 Biomet Manufacturing Corporation Femoral guide for implanting a femoral knee prosthesis
US7828802B2 (en) 2004-01-16 2010-11-09 Expanding Orthopedics, Inc. Bone fracture treatment devices and methods of their use
US7641664B2 (en) * 2004-02-12 2010-01-05 Warsaw Orthopedic, Inc. Surgical instrumentation and method for treatment of a spinal structure
US8029511B2 (en) * 2004-03-22 2011-10-04 Disc Dynamics, Inc. Multi-stage biomaterial injection system for spinal implants
WO2005094553A2 (en) * 2004-03-24 2005-10-13 Doctor's Research Group, Inc. Compositions for promoting bone growth and methods thereof
EP1732459A2 (en) * 2004-03-31 2006-12-20 Advanced Biomaterial Systems, Inc. Methods and devices for cavity creation in mammalian bone tissue
US7465318B2 (en) * 2004-04-15 2008-12-16 Soteira, Inc. Cement-directing orthopedic implants
US7803150B2 (en) * 2004-04-21 2010-09-28 Acclarent, Inc. Devices, systems and methods useable for treating sinusitis
US20050245938A1 (en) * 2004-04-28 2005-11-03 Kochan Jeffrey P Method and apparatus for minimally invasive repair of intervertebral discs and articular joints
US20080132899A1 (en) * 2004-05-17 2008-06-05 Shadduck John H Composite implant and method for treating bone abnormalities
JP2008500140A (en) * 2004-05-21 2008-01-10 メイヤーズ サージカル ソリューションズ, エルエルシー Fracture fixation and site stabilization system
US7846171B2 (en) 2004-05-27 2010-12-07 C.R. Bard, Inc. Method and apparatus for delivering a prosthetic fabric into a patient
US8142462B2 (en) 2004-05-28 2012-03-27 Cavitech, Llc Instruments and methods for reducing and stabilizing bone fractures
US7621952B2 (en) * 2004-06-07 2009-11-24 Dfine, Inc. Implants and methods for treating bone
US20060085081A1 (en) * 2004-06-07 2006-04-20 Shadduck John H Implants and methods for treating bone
US20060095138A1 (en) 2004-06-09 2006-05-04 Csaba Truckai Composites and methods for treating bone
FR2871366A1 (en) 2004-06-09 2005-12-16 Ceravic Soc Par Actions Simpli PROSTHETIC EXPANSIBLE BONE IMPLANT
US7776073B2 (en) * 2004-06-30 2010-08-17 Depuy Spine, Inc. In-situ formed posterolateral fusion system
CN106963464B (en) 2004-07-30 2019-11-05 德普伊新特斯产品有限责任公司 Surgical set
US20060085009A1 (en) * 2004-08-09 2006-04-20 Csaba Truckai Implants and methods for treating bone
US8038682B2 (en) * 2004-08-17 2011-10-18 Boston Scientific Scimed, Inc. Apparatus and methods for delivering compounds into vertebrae for vertebroplasty
US20080319445A9 (en) * 2004-08-17 2008-12-25 Scimed Life Systems, Inc. Apparatus and methods for delivering compounds into vertebrae for vertebroplasty
US8880191B2 (en) 2004-08-31 2014-11-04 Stephen Pyles Method of implanting a spinal cord stimulator lead having multiple obstruction-clearing features
US20060206183A1 (en) * 2004-08-31 2006-09-14 Pyles Stephen T Spinal cord stimulator lead for neurostimulation having a fluid delivery lumen and/0r a distensible balloon
JP2008511422A (en) * 2004-09-02 2008-04-17 クロストゥリーズ・メディカル・インコーポレーテッド Device and method for distraction of spinal disc space
WO2006034436A2 (en) 2004-09-21 2006-03-30 Stout Medical Group, L.P. Expandable support device and method of use
US20060229628A1 (en) * 2004-10-02 2006-10-12 Csaba Truckai Biomedical treatment systems and methods
US8048083B2 (en) * 2004-11-05 2011-11-01 Dfine, Inc. Bone treatment systems and methods
US7559932B2 (en) 2004-12-06 2009-07-14 Dfine, Inc. Bone treatment systems and methods
US7678116B2 (en) 2004-12-06 2010-03-16 Dfine, Inc. Bone treatment systems and methods
US20060100706A1 (en) * 2004-11-10 2006-05-11 Shadduck John H Stent systems and methods for spine treatment
US7682378B2 (en) 2004-11-10 2010-03-23 Dfine, Inc. Bone treatment systems and methods for introducing an abrading structure to abrade bone
US7799078B2 (en) * 2004-11-12 2010-09-21 Warsaw Orthopedic, Inc. Implantable vertebral lift
EP1814625A1 (en) * 2004-11-15 2007-08-08 Kyphon Inc. System and method for delivering a therapeutic agent for bone disease
US8562607B2 (en) 2004-11-19 2013-10-22 Dfine, Inc. Bone treatment systems and methods
US8070753B2 (en) 2004-12-06 2011-12-06 Dfine, Inc. Bone treatment systems and methods
US7717918B2 (en) * 2004-12-06 2010-05-18 Dfine, Inc. Bone treatment systems and methods
US7722620B2 (en) 2004-12-06 2010-05-25 Dfine, Inc. Bone treatment systems and methods
US20060149136A1 (en) * 2004-12-22 2006-07-06 Kyphon Inc. Elongating balloon device and method for soft tissue expansion
AR055833A1 (en) * 2005-01-07 2007-09-12 Celonova Biosciences Inc IMPLANTABLE THREE DIMENSIONAL BEAR SUPPORT
US20060184192A1 (en) * 2005-02-11 2006-08-17 Markworth Aaron D Systems and methods for providing cavities in interior body regions
CN101370634A (en) * 2005-02-16 2009-02-18 亚历山大·R·瓦卡若 Resorbable hollow devices for implantation and delivery of therapeutic agents
US7695479B1 (en) * 2005-04-12 2010-04-13 Biomet Manufacturing Corp. Femoral sizer
US20060247657A1 (en) * 2005-04-27 2006-11-02 Sdgi Holdings, Inc. Methods and systems for characterizing intervertebral disc space
US20060265076A1 (en) * 2005-05-03 2006-11-23 Disc Dynamics, Inc. Catheter holder for spinal implant
US9060820B2 (en) 2005-05-18 2015-06-23 Sonoma Orthopedic Products, Inc. Segmented intramedullary fracture fixation devices and methods
WO2010037038A2 (en) 2008-09-26 2010-04-01 Sonoma Orthopedic Products, Inc. Bone fixation device, tools and methods
US8961516B2 (en) 2005-05-18 2015-02-24 Sonoma Orthopedic Products, Inc. Straight intramedullary fracture fixation devices and methods
US20070050034A1 (en) * 2005-05-24 2007-03-01 Schwardt Jeffrey D Low-compliance expandable medical device
US7988735B2 (en) * 2005-06-15 2011-08-02 Matthew Yurek Mechanical apparatus and method for delivering materials into the inter-vertebral body space for nucleus replacement
KR100948082B1 (en) * 2005-06-15 2010-04-01 베절릴 엘엘씨 Tool and Technique for Continually Delivering an Orthopaedic Paste
KR20080047357A (en) * 2005-07-07 2008-05-28 크로스트리스 메디칼, 인코포레이티드 Devices and methods for the treatment of bone fracture
US20070078436A1 (en) * 2005-07-07 2007-04-05 Leung Andrea Y Balloon assisted apparatus and method for accessing an intervertebral disc
US20070010844A1 (en) * 2005-07-08 2007-01-11 Gorman Gong Radiopaque expandable body and methods
US20070010845A1 (en) * 2005-07-08 2007-01-11 Gorman Gong Directionally controlled expandable device and methods for use
US20070060933A1 (en) * 2005-07-11 2007-03-15 Meera Sankaran Curette heads
US8105236B2 (en) * 2005-07-11 2012-01-31 Kyphon Sarl Surgical access device, system, and methods of use
US20070006692A1 (en) * 2005-07-11 2007-01-11 Phan Christopher U Torque limiting device
US20070010824A1 (en) * 2005-07-11 2007-01-11 Hugues Malandain Products, systems and methods for delivering material to bone and other internal body parts
US20070055201A1 (en) * 2005-07-11 2007-03-08 Seto Christine L Systems and methods for providing cavities in interior body regions
US20070010848A1 (en) * 2005-07-11 2007-01-11 Andrea Leung Systems and methods for providing cavities in interior body regions
EP1909671B1 (en) * 2005-07-11 2012-01-18 Kyphon SÀRL System for inserting biocompatible filler materials in interior body regions
US8021365B2 (en) * 2005-07-11 2011-09-20 Kyphon Sarl Surgical device having interchangeable components and methods of use
EP1903949A2 (en) 2005-07-14 2008-04-02 Stout Medical Group, L.P. Expandable support device and method of use
US9381024B2 (en) 2005-07-31 2016-07-05 DePuy Synthes Products, Inc. Marked tools
US9918767B2 (en) 2005-08-01 2018-03-20 DePuy Synthes Products, Inc. Temperature control system
AU2006279558B2 (en) 2005-08-16 2012-05-17 Izi Medical Products, Llc Spinal tissue distraction devices
US8591583B2 (en) 2005-08-16 2013-11-26 Benvenue Medical, Inc. Devices for treating the spine
US8366773B2 (en) 2005-08-16 2013-02-05 Benvenue Medical, Inc. Apparatus and method for treating bone
US8540723B2 (en) 2009-04-14 2013-09-24 Dfine, Inc. Medical system and method of use
US9066769B2 (en) 2005-08-22 2015-06-30 Dfine, Inc. Bone treatment systems and methods
US8777479B2 (en) 2008-10-13 2014-07-15 Dfine, Inc. System for use in bone cement preparation and delivery
US20090012525A1 (en) 2005-09-01 2009-01-08 Eric Buehlmann Devices and systems for delivering bone fill material
US8900620B2 (en) 2005-10-13 2014-12-02 DePuy Synthes Products, LLC Drug-impregnated encasement
WO2007058943A2 (en) * 2005-11-10 2007-05-24 Zimmer, Inc. Minamally invasive orthopaedic delivery devices and tools
US20070123877A1 (en) * 2005-11-15 2007-05-31 Aoi Medical, Inc. Inflatable Device for Restoring Anatomy of Fractured Bone
US8360629B2 (en) 2005-11-22 2013-01-29 Depuy Spine, Inc. Mixing apparatus having central and planetary mixing elements
EP1968505A4 (en) 2005-11-23 2011-12-28 Crosstrees Medical Inc Devices and methods for the treatment of bone fracture
US7901409B2 (en) 2006-01-20 2011-03-08 Canaveral Villegas Living Trust Intramedullar devices and methods to reduce and/or fix damaged bone
US20070233250A1 (en) * 2006-02-07 2007-10-04 Shadduck John H Systems for treating bone
US20070213641A1 (en) * 2006-02-08 2007-09-13 Sdgi Holdings, Inc. Constrained balloon disc sizer
US20070233258A1 (en) * 2006-02-28 2007-10-04 Zimmer Spine, Inc. Vertebroplasty- device and method
US20070270970A1 (en) * 2006-03-14 2007-11-22 Sdgi Holdings, Inc. Spinal implants with improved wear resistance
US20070270971A1 (en) * 2006-03-14 2007-11-22 Sdgi Holdings, Inc. Intervertebral prosthetic disc with improved wear resistance
GB2436292B (en) * 2006-03-24 2011-03-16 Galley Geoffrey H Expandable spacing means for insertion between spinous processes of adjacent vertebrae
US20070233246A1 (en) * 2006-03-31 2007-10-04 Sdgi Holdings, Inc. Spinal implants with improved mechanical response
US20070232905A1 (en) * 2006-04-04 2007-10-04 Francis Tom J Unconstrained Balloon Sizer
JP2007275236A (en) 2006-04-05 2007-10-25 Olympus Terumo Biomaterials Corp Device for repairing vertebral body
US7806900B2 (en) 2006-04-26 2010-10-05 Illuminoss Medical, Inc. Apparatus and methods for delivery of reinforcing materials to bone
AU2007243353B2 (en) 2006-04-26 2012-05-31 Illuminoss Medical, Inc. Apparatus and methods for reinforcing bone
US20070255286A1 (en) * 2006-04-27 2007-11-01 Sdgi Holdings, Inc. Devices, apparatus, and methods for improved disc augmentation
US20070255406A1 (en) * 2006-04-27 2007-11-01 Sdgi Holdings, Inc. Devices, apparatus, and methods for bilateral approach to disc augmentation
US8133279B2 (en) * 2006-04-27 2012-03-13 Warsaw Orthopedic, Inc. Methods for treating an annulus defect of an intervertebral disc
JP5542273B2 (en) 2006-05-01 2014-07-09 スタウト メディカル グループ,エル.ピー. Expandable support device and method of use
US9089347B2 (en) * 2006-07-07 2015-07-28 Orthophoenix, Llc Medical device with dual expansion mechanism
US20080027456A1 (en) * 2006-07-19 2008-01-31 Csaba Truckai Bone treatment systems and methods
US20080021462A1 (en) * 2006-07-24 2008-01-24 Warsaw Orthopedic Inc. Spinal stabilization implants
US20080021557A1 (en) * 2006-07-24 2008-01-24 Warsaw Orthopedic, Inc. Spinal motion-preserving implants
US7758649B2 (en) * 2006-08-04 2010-07-20 Integrity Intellect Inc. Reversibly deformable implant
US8043362B2 (en) 2006-08-25 2011-10-25 Kyphon Sarl Apparatus and methods for use of expandable members in surgical applications
WO2008032322A2 (en) 2006-09-14 2008-03-20 Depuy Spine, Inc. Bone cement and methods of use thereof
US20080312637A1 (en) * 2007-06-15 2008-12-18 Kyphon Inc. Device and Methods for Introducing a Catheter into an Intervertebral Disc
US20080086142A1 (en) * 2006-10-06 2008-04-10 Kohm Andrew C Products and Methods for Delivery of Material to Bone and Other Internal Body Parts
US10850235B2 (en) 2006-10-09 2020-12-01 Minnetronix, Inc. Method for filtering cerebrospinal fluid (CSF) including monitoring CSF flow
JP2010505556A (en) 2006-10-09 2010-02-25 ニューロフルーディクス, インコーポレイテッド Cerebrospinal fluid purification system
US10632237B2 (en) 2006-10-09 2020-04-28 Minnetronix, Inc. Tangential flow filter system for the filtration of materials from biologic fluids
US8950929B2 (en) 2006-10-19 2015-02-10 DePuy Synthes Products, LLC Fluid delivery system
US20080195223A1 (en) * 2006-11-03 2008-08-14 Avram Allan Eddin Materials and Methods and Systems for Delivering Localized Medical Treatments
US7879041B2 (en) 2006-11-10 2011-02-01 Illuminoss Medical, Inc. Systems and methods for internal bone fixation
WO2008063265A1 (en) 2006-11-10 2008-05-29 Illuminoss Medical, Inc. Systems and methods for internal bone fixation
US20080114364A1 (en) * 2006-11-15 2008-05-15 Aoi Medical, Inc. Tissue cavitation device and method
EP2094177A2 (en) 2006-11-22 2009-09-02 Sonoma Orthopedic Products, Inc. Fracture fixation device, tools and methods
WO2008070863A2 (en) 2006-12-07 2008-06-12 Interventional Spine, Inc. Intervertebral implant
US8696679B2 (en) 2006-12-08 2014-04-15 Dfine, Inc. Bone treatment systems and methods
US9192397B2 (en) 2006-12-15 2015-11-24 Gmedelaware 2 Llc Devices and methods for fracture reduction
US9480485B2 (en) 2006-12-15 2016-11-01 Globus Medical, Inc. Devices and methods for vertebrostenting
WO2008076330A1 (en) 2006-12-15 2008-06-26 Soteira, Inc. Drills and methods for vertebrostenting
US7972382B2 (en) * 2006-12-26 2011-07-05 Warsaw Orthopedic, Inc. Minimally invasive spinal distraction devices and methods
WO2008095052A2 (en) 2007-01-30 2008-08-07 Loma Vista Medical, Inc., Biological navigation device
WO2008103832A2 (en) 2007-02-21 2008-08-28 Benvenue Medical, Inc. Devices for treating the spine
US20080215151A1 (en) * 2007-03-02 2008-09-04 Andrew Kohm Bone barrier device, system, and method
EP2162078A4 (en) * 2007-03-06 2011-04-06 Orthobond Inc Preparation tools and methods of using the same
US20080243122A1 (en) * 2007-03-29 2008-10-02 Kohm Andrew C Apparatuses and methods for bone screw augmentation
US20080243249A1 (en) * 2007-03-30 2008-10-02 Kohm Andrew C Devices for multipoint emplacement in a body part and methods of use of such devices
WO2008121404A1 (en) * 2007-03-30 2008-10-09 Kyphon Sarl Methods and systems for the diagnosis and treatment of medical conditions in the spine and other body parts
EP2155084B1 (en) 2007-04-03 2013-11-27 Dfine, Inc. Bone treatment systems
WO2008137428A2 (en) 2007-04-30 2008-11-13 Dfine, Inc. Bone treatment systems and methods
JP2010527705A (en) * 2007-05-21 2010-08-19 エーオーアイ メディカル インコーポレイテッド Bending type cavity forming device
US8900307B2 (en) 2007-06-26 2014-12-02 DePuy Synthes Products, LLC Highly lordosed fusion cage
US9597118B2 (en) 2007-07-20 2017-03-21 Dfine, Inc. Bone anchor apparatus and method
EP2195087A1 (en) * 2007-09-14 2010-06-16 Crosstrees Medical, Inc. Material control device for inserting material into a targeted anatomical region
WO2009039464A1 (en) * 2007-09-20 2009-03-26 Life Spine, Inc. Expandable spinal spacer
US20090088788A1 (en) * 2007-09-28 2009-04-02 Steven Mouw Methods and apparatus having multiple separately actuatable expandable members
US20090088789A1 (en) * 2007-09-28 2009-04-02 O'neil Michael J Balloon With Shape Control For Spinal Procedures
US9427289B2 (en) 2007-10-31 2016-08-30 Illuminoss Medical, Inc. Light source
WO2009064847A2 (en) 2007-11-16 2009-05-22 Synthes (U.S.A.) Porous containment device and associated method for stabilization of vertebral compression fractures
US9510885B2 (en) * 2007-11-16 2016-12-06 Osseon Llc Steerable and curvable cavity creation system
US20090131886A1 (en) 2007-11-16 2009-05-21 Liu Y King Steerable vertebroplasty system
US20090131867A1 (en) 2007-11-16 2009-05-21 Liu Y King Steerable vertebroplasty system with cavity creation element
US8403968B2 (en) 2007-12-26 2013-03-26 Illuminoss Medical, Inc. Apparatus and methods for repairing craniomaxillofacial bones using customized bone plates
ES2751997T3 (en) 2008-01-14 2020-04-02 Conventus Orthopaedics Inc Fracture repair apparatus
AU2009205896A1 (en) 2008-01-17 2009-07-23 Synthes Gmbh An expandable intervertebral implant and associated method of manufacturing the same
US9161798B2 (en) * 2008-02-01 2015-10-20 Dfine, Inc. Bone treatment systems and methods
US9445854B2 (en) 2008-02-01 2016-09-20 Dfine, Inc. Bone treatment systems and methods
US20090222096A1 (en) * 2008-02-28 2009-09-03 Warsaw Orthopedic, Inc. Multi-compartment expandable devices and methods for intervertebral disc expansion and augmentation
JP5509098B2 (en) 2008-02-28 2014-06-04 ディーエフアイエヌイー・インコーポレーテッド Bone treatment system and method
WO2009124269A1 (en) 2008-04-05 2009-10-08 Synthes Usa, Llc Expandable intervertebral implant
WO2009125242A1 (en) * 2008-04-08 2009-10-15 Vexim Apparatus for restoration of the spine and methods of use thereof
US9180416B2 (en) 2008-04-21 2015-11-10 Dfine, Inc. System for use in bone cement preparation and delivery
EP2265193B1 (en) 2008-04-21 2011-11-16 NFocus Neuromedical, Inc. Braid-ball embolic devices and delivery systems
US11471163B2 (en) 2008-05-01 2022-10-18 Aneuclose Llc Intrasaccular aneurysm occlusion device with net or mesh expanded by string-of-pearls embolies
US11484322B2 (en) 2018-01-03 2022-11-01 Aneuclose Llc Aneurysm neck bridge with a closeable opening or lumen through which embolic material is inserted into the aneurysm sac
WO2009134337A1 (en) * 2008-05-01 2009-11-05 Aneuclose Llc Aneurysm occlusion device
US11464518B2 (en) 2008-05-01 2022-10-11 Aneuclose Llc Proximal concave neck bridge with central lumen and distal net for occluding cerebral aneurysms
US9675482B2 (en) 2008-05-13 2017-06-13 Covidien Lp Braid implant delivery systems
US20090299401A1 (en) 2008-06-02 2009-12-03 Loma Vista Medical, Inc. Inflatable medical devices
CA2731735A1 (en) 2008-07-22 2010-01-28 Microtherapeutics, Inc. Vascular remodeling device
US7951111B2 (en) * 2008-10-10 2011-05-31 Intervalve, Inc. Valvuloplasty catheter and methods
US7951110B2 (en) * 2008-11-10 2011-05-31 Onset Medical Corporation Expandable spinal sheath and method of use
US20100211176A1 (en) 2008-11-12 2010-08-19 Stout Medical Group, L.P. Fixation device and method
US20100204795A1 (en) 2008-11-12 2010-08-12 Stout Medical Group, L.P. Fixation device and method
US20100160921A1 (en) * 2008-12-19 2010-06-24 Arthrocare Corporation Cancellous bone displacement system and methods of use
WO2010094032A2 (en) 2009-02-16 2010-08-19 Aoi Medical Inc. Trauma nail accumulator
WO2010103344A1 (en) 2009-03-12 2010-09-16 Vexim Apparatus for bone restoration of the spine and methods of use
US8535327B2 (en) 2009-03-17 2013-09-17 Benvenue Medical, Inc. Delivery apparatus for use with implantable medical devices
US9526620B2 (en) 2009-03-30 2016-12-27 DePuy Synthes Products, Inc. Zero profile spinal fusion cage
US8210729B2 (en) 2009-04-06 2012-07-03 Illuminoss Medical, Inc. Attachment system for light-conducting fibers
US8512338B2 (en) 2009-04-07 2013-08-20 Illuminoss Medical, Inc. Photodynamic bone stabilization systems and methods for reinforcing bone
US20100262190A1 (en) * 2009-04-09 2010-10-14 Warsaw Orthopedic, Inc. Spinal rod translation device
US20120136363A1 (en) * 2009-04-09 2012-05-31 Osseous Technologies Of America Collagen Biomaterial for Containment of Biomaterials
US20100298832A1 (en) 2009-05-20 2010-11-25 Osseon Therapeutics, Inc. Steerable curvable vertebroplasty drill
US8652183B1 (en) 2009-07-07 2014-02-18 Mari S Truman Multi-angle orthopedic expansion head fastener
US8870965B2 (en) 2009-08-19 2014-10-28 Illuminoss Medical, Inc. Devices and methods for bone alignment, stabilization and distraction
US8382840B2 (en) * 2009-09-03 2013-02-26 Zimmer Spine, Inc. Spinal implant delivery methods and devices
US8365758B2 (en) * 2009-10-30 2013-02-05 Angels' Share Innovations, LLC. Beverage barrel bladder system and apparatus
US20110202085A1 (en) 2009-11-09 2011-08-18 Siddharth Loganathan Braid Ball Embolic Device Features
US8226657B2 (en) 2009-11-10 2012-07-24 Carefusion 207, Inc. Systems and methods for vertebral or other bone structure height restoration and stabilization
US9095393B2 (en) 2012-05-30 2015-08-04 Carefusion 2200, Inc. Method for balloon-aided vertebral augmentation
US20110112507A1 (en) * 2009-11-10 2011-05-12 Carefusion 207, Inc. Curable material delivery systems and methods
US8894658B2 (en) 2009-11-10 2014-11-25 Carefusion 2200, Inc. Apparatus and method for stylet-guided vertebral augmentation
US8864768B2 (en) 2009-11-20 2014-10-21 Zimmer Knee Creations, Inc. Coordinate mapping system for joint treatment
WO2011063257A1 (en) 2009-11-20 2011-05-26 Knee Creations, Llc Instruments for targeting a joint defect
US8951261B2 (en) 2009-11-20 2015-02-10 Zimmer Knee Creations, Inc. Subchondral treatment of joint pain
WO2011063260A1 (en) 2009-11-20 2011-05-26 Knee Creations, Llc Bone-derived implantable devices for subchondral treatment of joint pain
US8821504B2 (en) 2009-11-20 2014-09-02 Zimmer Knee Creations, Inc. Method for treating joint pain and associated instruments
WO2011063240A1 (en) 2009-11-20 2011-05-26 Knee Creations, Llc Implantable devices for subchondral treatment of joint pain
CN102781348B (en) 2009-11-20 2015-07-15 膝部创造物有限责任公司 Navigation and positioning instruments for joint repair
EP2501306B1 (en) 2009-11-20 2020-02-12 Zimmer Knee Creations, Inc. Instruments for a variable angle approach to a joint
US8562619B2 (en) * 2009-12-03 2013-10-22 Industrial Technology Research Institute Injectable thermoplastic polymers for biological tissue repair
US20120016371A1 (en) * 2009-12-07 2012-01-19 O'halloran Damien Methods and Apparatus For Treating Vertebral Fractures
US9326799B2 (en) * 2009-12-07 2016-05-03 Globus Medical, Inc. Methods and apparatus for treating vertebral fractures
US11090092B2 (en) * 2009-12-07 2021-08-17 Globus Medical Inc. Methods and apparatus for treating vertebral fractures
US9358058B2 (en) * 2012-11-05 2016-06-07 Globus Medical, Inc. Methods and apparatus for treating vertebral fractures
US8734458B2 (en) * 2009-12-07 2014-05-27 Globus Medical, Inc. Methods and apparatus for treating vertebral fractures
US9393129B2 (en) 2009-12-10 2016-07-19 DePuy Synthes Products, Inc. Bellows-like expandable interbody fusion cage
US20110190776A1 (en) * 2009-12-18 2011-08-04 Palmaz Scientific, Inc. Interosteal and intramedullary implants and method of implanting same
US20110178520A1 (en) 2010-01-15 2011-07-21 Kyle Taylor Rotary-rigid orthopaedic rod
US8961518B2 (en) 2010-01-20 2015-02-24 Conventus Orthopaedics, Inc. Apparatus and methods for bone access and cavity preparation
WO2011094638A1 (en) 2010-01-28 2011-08-04 Micro Therapeutics, Inc. Vascular remodeling device
EP2528541B1 (en) 2010-01-28 2016-05-18 Covidien LP Vascular remodeling device
US20110190831A1 (en) * 2010-01-29 2011-08-04 Kyphon Sarl Steerable balloon catheter
WO2011112615A1 (en) 2010-03-08 2011-09-15 Krinke Todd A Apparatus and methods for securing a bone implant
US9125671B2 (en) 2010-04-29 2015-09-08 Dfine, Inc. System for use in treatment of vertebral fractures
US8535380B2 (en) 2010-05-13 2013-09-17 Stout Medical Group, L.P. Fixation device and method
US8684965B2 (en) 2010-06-21 2014-04-01 Illuminoss Medical, Inc. Photodynamic bone stabilization and drug delivery systems
US8979860B2 (en) 2010-06-24 2015-03-17 DePuy Synthes Products. LLC Enhanced cage insertion device
US9907560B2 (en) 2010-06-24 2018-03-06 DePuy Synthes Products, Inc. Flexible vertebral body shavers
KR20130047697A (en) * 2010-06-28 2013-05-08 신세스 게엠바하 Coated implant
US8623091B2 (en) 2010-06-29 2014-01-07 DePuy Synthes Products, LLC Distractible intervertebral implant
EP3552655B1 (en) 2010-07-13 2020-12-23 Loma Vista Medical, Inc. Inflatable medical devices
US9144501B1 (en) 2010-07-16 2015-09-29 Nuvasive, Inc. Fracture reduction device and methods
US9289943B2 (en) * 2010-08-09 2016-03-22 HALDOR Advanced Technologies L.T.D Apparatus and method for attaching an RF tag to a sponge item
EP2608747A4 (en) 2010-08-24 2015-02-11 Flexmedex Llc Support device and method for use
US9242081B2 (en) 2010-09-13 2016-01-26 Intervalve, Inc. Positionable valvuloplasty catheter
US9402732B2 (en) 2010-10-11 2016-08-02 DePuy Synthes Products, Inc. Expandable interspinous process spacer implant
US10188436B2 (en) 2010-11-09 2019-01-29 Loma Vista Medical, Inc. Inflatable medical devices
US9149286B1 (en) 2010-11-12 2015-10-06 Flexmedex, LLC Guidance tool and method for use
US8771276B2 (en) 2010-12-01 2014-07-08 Carefusion 2200, Inc. Systems and methods for forming a cavity in, and delivering curable material into, bone
EP2654584A1 (en) 2010-12-22 2013-10-30 Illuminoss Medical, Inc. Systems and methods for treating conditions and diseases of the spine
JP5868432B2 (en) 2011-02-11 2016-02-24 コヴィディエン リミテッド パートナーシップ Two-stage deployed aneurysm embolization device
US9089332B2 (en) 2011-03-25 2015-07-28 Covidien Lp Vascular remodeling device
US9358372B2 (en) 2011-03-25 2016-06-07 Vention Medical Advanced Components, Inc. Apparatus and methods for accessing and dilating bone structures using a narrow gauge cannula
ES2645945T3 (en) 2011-04-07 2017-12-11 Vexim Expandable Orthopedic Device
US8814873B2 (en) 2011-06-24 2014-08-26 Benvenue Medical, Inc. Devices and methods for treating bone tissue
US8454615B2 (en) * 2011-07-05 2013-06-04 Kyphon Sarl Combination directional and non-directional bone tamp
US9775661B2 (en) 2011-07-19 2017-10-03 Illuminoss Medical, Inc. Devices and methods for bone restructure and stabilization
US8936644B2 (en) 2011-07-19 2015-01-20 Illuminoss Medical, Inc. Systems and methods for joint stabilization
EP2747682A4 (en) 2011-08-23 2015-01-21 Flexmedex Llc Tissue removal device and method
US9060886B2 (en) 2011-09-29 2015-06-23 Covidien Lp Vascular remodeling device
JP2015033396A (en) 2011-12-02 2015-02-19 テルモ株式会社 Implant
TWI590843B (en) 2011-12-28 2017-07-11 信迪思有限公司 Films and methods of manufacture
US8734387B2 (en) 2012-01-13 2014-05-27 Warsaw Orthopedic, Inc. Expansion device for treatment of black triangle disease and method
US8939977B2 (en) 2012-07-10 2015-01-27 Illuminoss Medical, Inc. Systems and methods for separating bone fixation devices from introducer
TWI503097B (en) 2012-10-23 2015-10-11 Spirit Spine Holdings Corp Inc Bone fixation device
US9314248B2 (en) 2012-11-06 2016-04-19 Covidien Lp Multi-pivot thrombectomy device
US9687281B2 (en) 2012-12-20 2017-06-27 Illuminoss Medical, Inc. Distal tip for bone fixation devices
US9463307B2 (en) 2012-12-21 2016-10-11 Medtronic Xomed, Inc. Sinus dilation system and method
US9295571B2 (en) 2013-01-17 2016-03-29 Covidien Lp Methods and apparatus for luminal stenting
US9192420B2 (en) 2013-01-24 2015-11-24 Kyphon Sarl Surgical system and methods of use
US9351779B2 (en) * 2013-01-25 2016-05-31 Kyphon SÀRL Expandable device and methods of use
US9717601B2 (en) 2013-02-28 2017-08-01 DePuy Synthes Products, Inc. Expandable intervertebral implant, system, kit and method
US9522070B2 (en) 2013-03-07 2016-12-20 Interventional Spine, Inc. Intervertebral implant
US9149318B2 (en) * 2013-03-07 2015-10-06 Kyphon Sarl Low cost inflatable bone tamp
US9585761B2 (en) 2013-03-14 2017-03-07 DePuy Synthes Products, Inc. Angulated rings and bonded foils for use with balloons for fusion and dynamic stabilization
US9463105B2 (en) 2013-03-14 2016-10-11 Covidien Lp Methods and apparatus for luminal stenting
US9572676B2 (en) * 2013-03-14 2017-02-21 DePuy Synthes Products, Inc. Adjustable multi-volume balloon for spinal interventions
US9358120B2 (en) 2013-03-14 2016-06-07 DePuy Synthes Products, Inc. Expandable coil spinal implant
US10085783B2 (en) 2013-03-14 2018-10-02 Izi Medical Products, Llc Devices and methods for treating bone tissue
CN108433769B (en) 2013-03-15 2021-06-08 柯惠有限合伙公司 Occlusion device
US9814488B2 (en) 2013-03-15 2017-11-14 Globus Medical, Inc. Surgical probe incorporating a dilator
CN105555328B (en) 2013-06-21 2019-01-11 德普伊新特斯产品公司 film and manufacturing method
EP3079607A4 (en) 2013-12-12 2017-07-26 Conventus Orthopaedics, Inc. Tissue displacement tools and methods
FR3015221B1 (en) 2013-12-23 2017-09-01 Vexim EXPANSIBLE INTRAVERTEBRAL IMPLANT SYSTEM WITH POSTERIOR PEDICULAR FIXATION
US9770278B2 (en) 2014-01-17 2017-09-26 Arthrex, Inc. Dual tip guide wire
TWI528938B (en) 2014-03-21 2016-04-11 Spirit Spine Holdings Corp Inc Bone fixation device
US9814499B2 (en) 2014-09-30 2017-11-14 Arthrex, Inc. Intramedullary fracture fixation devices and methods
US11426290B2 (en) 2015-03-06 2022-08-30 DePuy Synthes Products, Inc. Expandable intervertebral implant, system, kit and method
US11147540B2 (en) 2015-07-01 2021-10-19 Minnetronix, Inc. Introducer sheath and puncture tool for the introduction and placement of a catheter in tissue
WO2017037491A1 (en) * 2015-09-04 2017-03-09 Terumo Europe N.V. Ethyleneoxide assisted expansion of tubing
US10478194B2 (en) 2015-09-23 2019-11-19 Covidien Lp Occlusive devices
CA3006975C (en) 2015-12-04 2022-02-22 Minnetronix, Inc. Systems and methods for the conditioning of cerebrospinal fluid
US11510788B2 (en) 2016-06-28 2022-11-29 Eit Emerging Implant Technologies Gmbh Expandable, angularly adjustable intervertebral cages
JP7019616B2 (en) 2016-06-28 2022-02-15 イーアイティー・エマージング・インプラント・テクノロジーズ・ゲーエムベーハー Expandable and angle adjustable intervertebral cage with range of motion joints
US10314632B2 (en) * 2016-10-07 2019-06-11 Medtronic Holding Company Sárl Surgical system and methods of use
EP3531934B1 (en) 2016-10-27 2024-08-21 Dfine, Inc. Articulating osteotome with cement delivery channel
JP7256119B2 (en) 2016-11-28 2023-04-11 ディファイン インコーポレイテッド Tumor resection device and related method
WO2018107036A1 (en) 2016-12-09 2018-06-14 Dfine, Inc. Medical devices for treating hard tissues and related methods
US10888433B2 (en) 2016-12-14 2021-01-12 DePuy Synthes Products, Inc. Intervertebral implant inserter and related methods
EP3565486B1 (en) 2017-01-06 2021-11-10 Dfine, Inc. Osteotome with a distal portion for simultaneous advancement and articulation
US10398563B2 (en) 2017-05-08 2019-09-03 Medos International Sarl Expandable cage
US11344424B2 (en) 2017-06-14 2022-05-31 Medos International Sarl Expandable intervertebral implant and related methods
US10918426B2 (en) 2017-07-04 2021-02-16 Conventus Orthopaedics, Inc. Apparatus and methods for treatment of a bone
US10940016B2 (en) 2017-07-05 2021-03-09 Medos International Sarl Expandable intervertebral fusion cage
WO2019133775A1 (en) * 2017-12-28 2019-07-04 Cardio Voyage Innovations, Llc Directional kyphoplasty device and method of using such a device
WO2020006239A1 (en) 2018-06-27 2020-01-02 Illuminoss Medical, Inc. Systems and methods for bone stabilization and fixation
US11446156B2 (en) 2018-10-25 2022-09-20 Medos International Sarl Expandable intervertebral implant, inserter instrument, and related methods
WO2020097339A1 (en) 2018-11-08 2020-05-14 Dfine, Inc. Tumor ablation device and related systems and methods
TWI731379B (en) 2019-07-31 2021-06-21 中央醫療器材股份有限公司 Vertebral fixation device
TWI731380B (en) 2019-07-31 2021-06-21 中央醫療器材股份有限公司 Spinal implants
EP4031040A4 (en) 2019-09-18 2023-11-15 Merit Medical Systems, Inc. Osteotome with inflatable portion and multiwire articulation
US11426286B2 (en) 2020-03-06 2022-08-30 Eit Emerging Implant Technologies Gmbh Expandable intervertebral implant
US11850160B2 (en) 2021-03-26 2023-12-26 Medos International Sarl Expandable lordotic intervertebral fusion cage
US11752009B2 (en) 2021-04-06 2023-09-12 Medos International Sarl Expandable intervertebral fusion cage
US11298238B1 (en) * 2021-07-23 2022-04-12 Focus Medical Company, Llc Balloon kyphoplasty surgical device and method
US12090064B2 (en) 2022-03-01 2024-09-17 Medos International Sarl Stabilization members for expandable intervertebral implants, and related systems and methods
WO2023200758A1 (en) * 2022-04-14 2023-10-19 Brijjit Medical, Inc. Thermoforming apparatuses, machines, systems, and methods

Citations (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3800788A (en) * 1972-07-12 1974-04-02 N White Antral catheter for reduction of fractures
US3875595A (en) * 1974-04-15 1975-04-08 Edward C Froning Intervertebral disc prosthesis and instruments for locating same
US4083369A (en) * 1976-07-02 1978-04-11 Manfred Sinnreich Surgical instruments
US4130617A (en) * 1977-12-30 1978-12-19 Airco, Inc. Method of making endotracheal tube cuffs
US4313434A (en) * 1980-10-17 1982-02-02 David Segal Fracture fixation
US4327736A (en) * 1979-11-20 1982-05-04 Kanji Inoue Balloon catheter
US4448195A (en) * 1981-05-08 1984-05-15 Leveen Harry H Reinforced balloon catheter
US4706670A (en) * 1985-11-26 1987-11-17 Meadox Surgimed A/S Dilatation catheter
US4772287A (en) * 1987-08-20 1988-09-20 Cedar Surgical, Inc. Prosthetic disc and method of implanting
US4969888A (en) * 1989-02-09 1990-11-13 Arie Scholten Surgical protocol for fixation of osteoporotic bone using inflatable device
US5019042A (en) * 1988-11-23 1991-05-28 Harvinder Sahota Balloon catheters
US5102413A (en) * 1990-11-14 1992-04-07 Poddar Satish B Inflatable bone fixation device
US5108395A (en) * 1989-09-18 1992-04-28 Societe De Fabrication De Materiel Orthopedique - Sofamor Implant for anterior dorsolumbar spinal osteosynthesis, intended for the correction of kyphoses
US5167665A (en) * 1991-12-31 1992-12-01 Mckinney William W Method of attaching objects to bone
US5254091A (en) * 1991-01-08 1993-10-19 Applied Medical Resources Corporation Low profile balloon catheter and method for making same
US5295994A (en) * 1991-11-15 1994-03-22 Bonutti Peter M Active cannulas
US5331975A (en) * 1990-03-02 1994-07-26 Bonutti Peter M Fluid operated retractors
US5352199A (en) * 1993-05-28 1994-10-04 Numed, Inc. Balloon catheter
US5423850A (en) * 1993-10-01 1995-06-13 Berger; J. Lee Balloon compressor for internal fixation of bone fractures
US5439447A (en) * 1994-02-09 1995-08-08 Baxter International Inc. Balloon dilation catheter with hypotube
US5549679A (en) * 1994-05-20 1996-08-27 Kuslich; Stephen D. Expandable fabric implant for stabilizing the spinal motion segment
US5620457A (en) * 1994-11-23 1997-04-15 Medinol Ltd. Catheter balloon
US5782740A (en) * 1996-08-29 1998-07-21 Advanced Cardiovascular Systems, Inc. Radiation dose delivery catheter with reinforcing mandrel
US5788703A (en) * 1995-02-17 1998-08-04 Allo Pro Ag Apparatus for the placement of a medullary space blocker
US5897557A (en) * 1998-03-13 1999-04-27 Chin; Albert K. Bone fracture reinforcement structure and method
US5951514A (en) * 1997-03-07 1999-09-14 Sahota; Harvinder Multi-lobe perfusion balloon
US5972015A (en) * 1997-08-15 1999-10-26 Kyphon Inc. Expandable, asymetric structures for deployment in interior body regions
US6235043B1 (en) * 1994-01-26 2001-05-22 Kyphon, Inc. Inflatable device for use in surgical protocol relating to fixation of bone
US6241734B1 (en) * 1998-08-14 2001-06-05 Kyphon, Inc. Systems and methods for placing materials into bone
US6248110B1 (en) * 1994-01-26 2001-06-19 Kyphon, Inc. Systems and methods for treating fractured or diseased bone using expandable bodies
US6852095B1 (en) * 1997-07-09 2005-02-08 Charles D. Ray Interbody device and method for treatment of osteoporotic vertebral collapse

Family Cites Families (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US402307A (en) * 1889-04-30 Hammock-support
US702789A (en) * 1902-03-20 1902-06-17 Charles Gordon Gibson Dilator.
US2849002A (en) 1956-03-12 1958-08-26 Vincent J Oddo Haemostatic catheter
US3045677A (en) * 1960-05-03 1962-07-24 American Cystoscope Makers Inc Inflatable balloon catheter
US3154077A (en) 1962-06-04 1964-10-27 Joseph P Cannon Hemostatic device for anal surgery
DE1906284A1 (en) 1969-02-08 1970-09-03 Dr Esfandiar Shahrestani Endoprosthesis, especially for hip joints
US3640282A (en) 1970-08-06 1972-02-08 Jack M Kamen Tracheal tube with normally expanded balloon cuff
DE2112139B2 (en) 1971-03-13 1973-02-01 Fischer, Artur, 7241 Tumhngen SLEEVE-SHAPED CONNECTOR FOR COMPRESSION OSTEOSYNTHESIS IN TUBE BONE Fractures
US3850176A (en) 1972-02-07 1974-11-26 G Gottschalk Nasal tampon
US3889685A (en) 1973-11-02 1975-06-17 Cutter Lab Tubular unit with vessel engaging cuff structure
US4261339A (en) 1978-03-06 1981-04-14 Datascope Corp. Balloon catheter with rotatable support
US4302855A (en) * 1979-04-27 1981-12-01 Swanson Alfred B Plug for the intramedallary canal of a bone and method
US4299226A (en) * 1979-08-08 1981-11-10 Banka Vidya S Coronary dilation method
US4292974A (en) 1980-01-30 1981-10-06 Thomas J. Fogarty Dilatation catheter apparatus and method
US4338942A (en) 1980-10-20 1982-07-13 Fogarty Thomas J Dilatation catherter apparatus
US4483340A (en) * 1980-10-20 1984-11-20 Thomas J. Fogarty Dilatation catheter
US4402307A (en) 1980-10-31 1983-09-06 Datascope Corp. Balloon catheter with rotatable energy storing support member
US4467790A (en) 1981-04-13 1984-08-28 Peter Schiff Percutaneous balloon
US4531512A (en) 1981-06-15 1985-07-30 Datascope Corporation Wrapping system for intra-aortic balloon utilizing a wrapping envelope
US4488549A (en) * 1981-08-25 1984-12-18 University Of Exeter Pressurization of cement in bones
US4462394A (en) * 1982-05-03 1984-07-31 Howmedica, Inc. Intramedullary canal seal for cement pressurization
US4490421A (en) 1983-07-05 1984-12-25 E. I. Du Pont De Nemours And Company Balloon and manufacture thereof
US4686973A (en) * 1984-10-12 1987-08-18 Dow Corning Corporation Method of making an intramedullary bone plug and bone plug made thereby
US4697584A (en) * 1984-10-12 1987-10-06 Darrel W. Haynes Device and method for plugging an intramedullary bone canal
US4705510A (en) * 1984-12-18 1987-11-10 The Kendall Company Nephrostomy catheter with formed tip
US5102390A (en) 1985-05-02 1992-04-07 C. R. Bard, Inc. Microdilatation probe and system for performing angioplasty in highly stenosed blood vessels
US5104376A (en) 1985-05-02 1992-04-14 C. R. Bard, Inc. Torsionally rigid balloon dilatation probe
US4917088A (en) 1985-05-02 1990-04-17 C. R. Bard, Inc. Balloon dilation probe
US4627434A (en) * 1985-05-03 1986-12-09 Murray William M Bone cement system and method
US4921483A (en) 1985-12-19 1990-05-01 Leocor, Inc. Angioplasty catheter
US4714478A (en) * 1986-01-17 1987-12-22 Fischer William B Prosthesis, method, and tool for installing same
US5350395A (en) * 1986-04-15 1994-09-27 Yock Paul G Angioplasty apparatus facilitating rapid exchanges
US4823815A (en) * 1986-09-19 1989-04-25 Mentor Corporation Tissue expanding device and method of making same
EP0274411A3 (en) 1987-01-09 1988-11-30 C.R. Bard, Inc. Thin wall high strength balloon and method of manufacture
US4848344A (en) * 1987-11-13 1989-07-18 Cook, Inc. Balloon guide
US4963313A (en) 1987-11-30 1990-10-16 Boston Scientific Corporation Balloon catheter
US4938676A (en) 1988-10-04 1990-07-03 Cordis Corporation Apparatus for manufacturing balloons for medical devices
US4906244A (en) 1988-10-04 1990-03-06 Cordis Corporation Balloons for medical devices and fabrication thereof
US5090957A (en) * 1988-10-05 1992-02-25 Abiomed, Inc. Intraaortic balloon insertion
US4983167A (en) 1988-11-23 1991-01-08 Harvinder Sahota Balloon catheters
EP0439202B1 (en) 1989-07-24 1993-09-29 Cordis Corporation Apparatus and method for manufacturing balloons for medical devices
ES2043289T3 (en) 1989-09-25 1993-12-16 Schneider Usa Inc THE EXTRUSION OF MULTIPLE LAYERS AS A PROCEDURE FOR MAKING ANGIOPLASTY BALLS.
US5116305A (en) * 1990-02-01 1992-05-26 Abiomed, Inc. Curved intra aortic balloon with non-folding inflated balloon membrane
US5163949A (en) * 1990-03-02 1992-11-17 Bonutti Peter M Fluid operated retractors
WO1991017788A1 (en) 1990-05-11 1991-11-28 Saab Mark A High-strength, thin-walled single piece catheters
US5163989A (en) * 1990-08-27 1992-11-17 Advanced Cardiovascular Systems, Inc. Method for forming a balloon mold and the use of such mold
US5033481A (en) * 1990-10-12 1991-07-23 Inamed Development Company Intraoperative or interoperative longitudinal tissue expander
CS277533B6 (en) * 1990-12-29 1993-03-17 Krajicek Milan Fixed osteaosynthesis appliance
WO1992019440A1 (en) 1991-05-01 1992-11-12 Danforth Biomedical, Inc. Improved balloon catheter of low molecular weight pet
US5766151A (en) * 1991-07-16 1998-06-16 Heartport, Inc. Endovascular system for arresting the heart
JPH05192408A (en) 1991-09-06 1993-08-03 C R Bard Inc Production of expansion balloon
US5415635A (en) 1992-07-21 1995-05-16 Advanced Cardiovascular Systems, Inc. Balloon assembly with separately inflatable sections
JPH07509165A (en) 1992-07-28 1995-10-12 アドヴァンスト・カーディオヴァスキュラー・システムズ・インコーポレイテッド Low profile catheter with expandable outer tubular member
US5348538A (en) * 1992-09-29 1994-09-20 Scimed Life Systems, Inc. Shrinking balloon catheter having nonlinear or hybrid compliance curve
US5500180A (en) 1992-09-30 1996-03-19 C. R. Bard, Inc. Method of making a distensible dilatation balloon using a block copolymer
JP3577082B2 (en) * 1993-10-01 2004-10-13 ボストン・サイエンティフィック・コーポレーション Medical device balloon made of thermoplastic elastomer
US5480400A (en) * 1993-10-01 1996-01-02 Berger; J. Lee Method and device for internal fixation of bone fractures
NZ279442A (en) 1994-01-26 1998-02-26 Mark A Reiley Bone treatment device; inflatable balloon for insertion into a bone; balloon details
US5468245A (en) * 1994-02-03 1995-11-21 Vargas, Iii; Joseph H. Biomedical cement bonding enhancer
DE4480681C2 (en) 1994-02-17 2001-09-27 Scimed Life Systems Inc Process for the production of catheter balloons and oriented balloons produced thereafter
US5843116A (en) 1996-05-02 1998-12-01 Cardiovascular Dynamics, Inc. Focalized intraluminal balloons
US5888220A (en) * 1994-05-06 1999-03-30 Advanced Bio Surfaces, Inc. Articulating joint repair
US5587125A (en) 1994-08-15 1996-12-24 Schneider (Usa) Inc. Non-coextrusion method of making multi-layer angioplasty balloons
WO1996012516A1 (en) 1994-10-19 1996-05-02 Advanced Cardiovascular Systems, Inc. High strength dilatation balloons
CA2205666A1 (en) * 1994-11-23 1996-05-30 Micro Interventional Systems, Inc. High torque balloon catheter
NL9500468A (en) 1995-03-08 1996-10-01 Cordis Europ Balloon catheter and method of making it.
US5645789A (en) 1995-07-20 1997-07-08 Navius Corporation Distensible pet balloon and method of manufacture
WO1997017099A1 (en) 1995-11-06 1997-05-15 C.R. Bard, Inc. Balloon catheter for drug application
DE69611378T2 (en) 1995-11-08 2001-04-26 Scimed Life Systems, Inc. METHOD FOR BALLOON PRODUCTION BY COLD DRAWING / NECKING
US5827298A (en) * 1995-11-17 1998-10-27 Innovasive Devices, Inc. Surgical fastening system and method for using the same
NL1001878C2 (en) 1995-12-12 1997-06-17 Cordis Europ A method of manufacturing a stent and a tubular member and catheter therefor.
US5741282A (en) 1996-01-22 1998-04-21 The Anspach Effort, Inc. Soft tissue fastener device
WO1998003218A1 (en) 1996-07-23 1998-01-29 Scimed Life Systems, Inc. High compliance, high strength catheter balloons useful for treatment of gastrointestinal lesions
US5910101A (en) 1996-08-29 1999-06-08 Advanced Cardiovascular Systems, Inc. Device for loading and centering a vascular radiation therapy source
US5868776A (en) * 1996-09-03 1999-02-09 Ideas For Medicine, Inc. Overlay dual balloon catheter and method for use thereof
NL1004162C2 (en) 1996-10-01 1998-04-02 Cordis Europ Balloon catheter for stent delivery.
JP2002505592A (en) * 1996-11-15 2002-02-19 アドバンスト バイオ サーフェイシズ,インコーポレイティド Biomaterial systems used to repair tissue in situ
ATE235196T1 (en) * 1997-04-16 2003-04-15 Sulzer Orthopaedie Ag FILLING DEVICE FOR BONE CEMENT
DE69840721D1 (en) 1997-06-09 2009-05-20 Kyphon S A R L ARRANGEMENT FOR TREATING BONE BREAKING OR DAMAGE BY EXPANDABLE BODIES
US6048346A (en) 1997-08-13 2000-04-11 Kyphon Inc. Systems and methods for injecting flowable materials into bones
US5938582A (en) * 1997-09-26 1999-08-17 Medtronic, Inc. Radiation delivery centering catheter
AU1630599A (en) 1997-12-08 1999-06-28 Kyphon, Inc. Systems and methods using expandable bodies to push apart cortical bone surfaces
US6468279B1 (en) 1998-01-27 2002-10-22 Kyphon Inc. Slip-fit handle for hand-held instruments that access interior body regions
US6440138B1 (en) 1998-04-06 2002-08-27 Kyphon Inc. Structures and methods for creating cavities in interior body regions
ES2354492T3 (en) 1998-06-01 2011-03-15 Kyphon Sarl PREFORMED STRUCTURES EXPANDABLE FOR DEPLOYMENT IN INTERNAL BODY REGIONS.
US6719773B1 (en) * 1998-06-01 2004-04-13 Kyphon Inc. Expandable structures for deployment in interior body regions
US6152943A (en) 1998-08-14 2000-11-28 Incept Llc Methods and apparatus for intraluminal deposition of hydrogels
RO116980B1 (en) 1998-12-07 2001-08-30 Miron Procop Process and device for the centering and alignment of two semi-couplings
US6200325B1 (en) 1999-03-31 2001-03-13 Advanced Cardiovascular Systems, Inc. Balloon catheter and stent deploying catheter system
US7081122B1 (en) 1999-10-19 2006-07-25 Kyphon Inc. Hand-held instruments that access interior body regions
USD439980S1 (en) 1999-10-19 2001-04-03 Kyphon, Inc. Hand-held surgical instrument
ATE318559T1 (en) 2000-04-05 2006-03-15 Kyphon Inc DEVICES FOR TREATING BROKEN AND/OR DISEASE BONES

Patent Citations (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3800788A (en) * 1972-07-12 1974-04-02 N White Antral catheter for reduction of fractures
US3875595A (en) * 1974-04-15 1975-04-08 Edward C Froning Intervertebral disc prosthesis and instruments for locating same
US4083369A (en) * 1976-07-02 1978-04-11 Manfred Sinnreich Surgical instruments
US4130617A (en) * 1977-12-30 1978-12-19 Airco, Inc. Method of making endotracheal tube cuffs
US4327736A (en) * 1979-11-20 1982-05-04 Kanji Inoue Balloon catheter
US4313434A (en) * 1980-10-17 1982-02-02 David Segal Fracture fixation
US4448195A (en) * 1981-05-08 1984-05-15 Leveen Harry H Reinforced balloon catheter
US4706670A (en) * 1985-11-26 1987-11-17 Meadox Surgimed A/S Dilatation catheter
US4772287A (en) * 1987-08-20 1988-09-20 Cedar Surgical, Inc. Prosthetic disc and method of implanting
US5019042A (en) * 1988-11-23 1991-05-28 Harvinder Sahota Balloon catheters
US4969888A (en) * 1989-02-09 1990-11-13 Arie Scholten Surgical protocol for fixation of osteoporotic bone using inflatable device
US5108404A (en) * 1989-02-09 1992-04-28 Arie Scholten Surgical protocol for fixation of bone using inflatable device
US5108395A (en) * 1989-09-18 1992-04-28 Societe De Fabrication De Materiel Orthopedique - Sofamor Implant for anterior dorsolumbar spinal osteosynthesis, intended for the correction of kyphoses
US5331975A (en) * 1990-03-02 1994-07-26 Bonutti Peter M Fluid operated retractors
US5102413A (en) * 1990-11-14 1992-04-07 Poddar Satish B Inflatable bone fixation device
US5254091A (en) * 1991-01-08 1993-10-19 Applied Medical Resources Corporation Low profile balloon catheter and method for making same
US5295994A (en) * 1991-11-15 1994-03-22 Bonutti Peter M Active cannulas
US5167665A (en) * 1991-12-31 1992-12-01 Mckinney William W Method of attaching objects to bone
US5352199A (en) * 1993-05-28 1994-10-04 Numed, Inc. Balloon catheter
US5423850A (en) * 1993-10-01 1995-06-13 Berger; J. Lee Balloon compressor for internal fixation of bone fractures
US6235043B1 (en) * 1994-01-26 2001-05-22 Kyphon, Inc. Inflatable device for use in surgical protocol relating to fixation of bone
US6423083B2 (en) * 1994-01-26 2002-07-23 Kyphon Inc. Inflatable device for use in surgical protocol relating to fixation of bone
US6248110B1 (en) * 1994-01-26 2001-06-19 Kyphon, Inc. Systems and methods for treating fractured or diseased bone using expandable bodies
US5439447A (en) * 1994-02-09 1995-08-08 Baxter International Inc. Balloon dilation catheter with hypotube
US5549679A (en) * 1994-05-20 1996-08-27 Kuslich; Stephen D. Expandable fabric implant for stabilizing the spinal motion segment
US5620457A (en) * 1994-11-23 1997-04-15 Medinol Ltd. Catheter balloon
US5788703A (en) * 1995-02-17 1998-08-04 Allo Pro Ag Apparatus for the placement of a medullary space blocker
US5782740A (en) * 1996-08-29 1998-07-21 Advanced Cardiovascular Systems, Inc. Radiation dose delivery catheter with reinforcing mandrel
US5951514A (en) * 1997-03-07 1999-09-14 Sahota; Harvinder Multi-lobe perfusion balloon
US6852095B1 (en) * 1997-07-09 2005-02-08 Charles D. Ray Interbody device and method for treatment of osteoporotic vertebral collapse
US5972015A (en) * 1997-08-15 1999-10-26 Kyphon Inc. Expandable, asymetric structures for deployment in interior body regions
US5897557A (en) * 1998-03-13 1999-04-27 Chin; Albert K. Bone fracture reinforcement structure and method
US6241734B1 (en) * 1998-08-14 2001-06-05 Kyphon, Inc. Systems and methods for placing materials into bone

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8559804B1 (en) 2006-04-07 2013-10-15 Lab Partners Associates, Inc. Wireless camera flash synchronizer system and method
US7702228B2 (en) 2006-04-07 2010-04-20 Lab Partners Associates, Inc. Wireless camera flash synchronizer system and method
US7970267B1 (en) 2006-04-07 2011-06-28 Lab Partners Associates, Inc. Wireless camera flash synchronizer system and method
US8180210B2 (en) 2006-04-07 2012-05-15 Lab Partners Associates, Inc. Wireless camera flash synchronizer system and method
US20090034952A1 (en) * 2006-04-07 2009-02-05 Lab Partners Associates, Inc. Wireless Camera Flash Synchronizer System and Method
US11033398B2 (en) 2007-03-15 2021-06-15 Ortho-Space Ltd. Shoulder implant for simulating a bursa
US20110123185A1 (en) * 2007-05-29 2011-05-26 Lab Partners Associates, Inc. External Photographic Wireless TTL Communication Device and Method
US8326140B2 (en) 2007-05-29 2012-12-04 Lab Partners Associates, Inc. External photographic wireless communication device and method
US8331776B2 (en) 2007-05-29 2012-12-11 Lab Partners Associates, Inc. External photographic wireless TTL communication device and method
US8571406B2 (en) 2009-02-12 2013-10-29 Lab Partners Associates, Inc. Early photographic predictor signal synchronization system and method
US8326141B1 (en) 2009-02-12 2012-12-04 Lab Partners Associates, Inc. Systems and methods for changing power states of a remote device using one or more camera body controls and a preset delay
US8614766B1 (en) 2009-02-12 2013-12-24 Lab Partners Associates, Inc. Systems and methods for controlling a power state of a remote device using camera body backlighting control signaling
US8705950B2 (en) 2009-02-12 2014-04-22 Lab Partners Associates, Inc. Early photographic critical point synchronization system and method
US8917350B2 (en) 2009-02-12 2014-12-23 Lab Patners Associates, Inc. Early photographic synchronization system and method
US8326136B1 (en) 2009-02-12 2012-12-04 Lab Partners Associates, Inc. Systems and methods for communicating with a device using one or more camera body controls
US9220554B2 (en) 2010-02-18 2015-12-29 Globus Medical, Inc. Methods and apparatus for treating vertebral fractures
US11826228B2 (en) 2011-10-18 2023-11-28 Stryker European Operations Limited Prosthetic devices
US10398485B2 (en) 2015-07-15 2019-09-03 KyphEZE, Inc. Bone expansion devices and methods
EP3322366A4 (en) * 2015-07-15 2019-03-20 Mayo Foundation for Medical Education and Research Bone expansion devices and methods
US11883083B2 (en) 2015-07-15 2024-01-30 KyphEZE, Inc. Bone expansion systems and methods
US10959761B2 (en) 2015-09-18 2021-03-30 Ortho-Space Ltd. Intramedullary fixated subacromial spacers
US11045981B2 (en) 2017-01-30 2021-06-29 Ortho-Space Ltd. Processing machine and methods for processing dip-molded articles
US11229466B2 (en) 2018-01-12 2022-01-25 KyphEZE, Inc. Bone expansion systems and methods

Also Published As

Publication number Publication date
US20020156482A1 (en) 2002-10-24
AU756969B2 (en) 2003-01-30
JP4393706B2 (en) 2010-01-06
US20040267271A9 (en) 2004-12-30
DE69942858D1 (en) 2010-11-25
ATE484247T1 (en) 2010-10-15
US6979341B2 (en) 2005-12-27
ES2354492T3 (en) 2011-03-15
NZ508401A (en) 2003-07-25
US20040010263A1 (en) 2004-01-15
JP4812786B2 (en) 2011-11-09
EP1083836B1 (en) 2010-10-13
NO20006089D0 (en) 2000-11-30
EP1083836A1 (en) 2001-03-21
CA2333761C (en) 2008-05-27
JP2002516697A (en) 2002-06-11
US20060095064A1 (en) 2006-05-04
IL140013A0 (en) 2002-02-10
CA2333761A1 (en) 1999-12-09
AU4325099A (en) 1999-12-20
WO1999062416A1 (en) 1999-12-09
JP2008161697A (en) 2008-07-17
US6607544B1 (en) 2003-08-19
EP1083836A4 (en) 2008-04-09
NO20006089L (en) 2001-01-24

Similar Documents

Publication Publication Date Title
US6979341B2 (en) Expandable preformed structures for deployment in interior body regions
US7722624B2 (en) Expandable structures for deployment in interior body regions
JP4493629B2 (en) System for treating broken or diseased bone using an inflatable body
US6623505B2 (en) Expandable structures for deployment in interior body regions
KR100591645B1 (en) Systems for treating fractured or diseased bone using expandable bodies
US7241303B2 (en) Devices and methods using an expandable body with internal restraint for compressing cancellous bone
US20070021835A1 (en) Systems and methods for providing prostheses
US9782572B2 (en) Apparatus and methods for treating bone structures, tissues and ducts using a narrow gauge cannula system
JP2018527145A (en) Implantable nucleus pulposus prosthesis
CA2621208A1 (en) Expandable preformed structures for deployment in interior body regions

Legal Events

Date Code Title Description
AS Assignment

Owner name: MEDTRONIC SPINE LLC, CALIFORNIA

Free format text: CHANGE OF NAME;ASSIGNOR:KYPHON INC;REEL/FRAME:020993/0042

Effective date: 20080118

Owner name: MEDTRONIC SPINE LLC,CALIFORNIA

Free format text: CHANGE OF NAME;ASSIGNOR:KYPHON INC;REEL/FRAME:020993/0042

Effective date: 20080118

AS Assignment

Owner name: KYPHON SARL, SWITZERLAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MEDTRONIC SPINE LLC;REEL/FRAME:021070/0278

Effective date: 20080325

Owner name: KYPHON SARL,SWITZERLAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MEDTRONIC SPINE LLC;REEL/FRAME:021070/0278

Effective date: 20080325

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: ORTHOPHOENIX, LLC, TEXAS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:KYPHON SARL;REEL/FRAME:035307/0018

Effective date: 20130425